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ABSTRACT 
 
KALLADAIPPU is the most common disease in our country. The evidence of 
the disease KALLADAIPPU was derived from YUGI VAIDHIYA CHINTHAMANI 
800, by Dr.K.Anbarasu B.S.M.S (Page.No.283). The clinical features of 
KALLADAIPPU can be correlated with UROLITHIASIS in modern science. 
Urolithiasis is a term originated from three Greek words “ouron” for urine, “oros” for 
flow, and “lithos” for stone. It is the formation of calculi which are formed or located 
anywhere in the urinary system (i.e. kidneys, bladder, urethrae, and urinary tract).  
           Many herbal and herbal-mineral formulations have been described in Siddha 
text books. One such drug NERUNJI VER KUDINEER mentioned in the book of 
AATHMARATCHAMIRTHAM ENNUM VAIDHYA SARASANGIRAGAM 
(Page.no:349).  A total of 40 patients of both sex (20 OPD and 20 IPD) were selected 
and administered with the clinical trial medicine “NERUNJI VER KUDINEER” 100 
ml BID at PG Department of Pothu Maruthuvam, Govt. Siddha Medical College and 
Hospital, Palayamkottai. The whole study period is between August 2018 and June 
2019. 
The clinical trial medicine was subjected to Biochemical, Toxicity and 
Pharmacological studies. In clinical study 75% of out patients and 50% of In patients 
showed Good response. And 25% of Out patients and 45% In patients showed 
Moderate response.  Poor response in 5% of IPD. No Adverse reaction was found in 
this clinical study. The statistical analysis showed good significant value (P<0.0001). 
The Nerunji ver Kudineer is safe and effective and affordable cost in the treatment of 
Kalladaippu Noi (Urolithiasis).  
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CHAPTER-I 
INTRODUCTION 
               The Siddha system is one of the oldest systems of medicine in India.The 
term siddha means achievements and Siddhars were saintly persons who achieved 
results in medicine. The siddha system is largely therapeutic in nature.The word 
Siddha comes from the tamil word Siddhi which means perfection.According to 
popular belief, the siddha system of medicine is divine in origin. Siddhars were 
spiritual masters who possessed the siddhis or unique powers. The basic theory of 
Siddha system of medicine is “Food is medicine, Medicine is food”.According to the 
siddha medicine system diet and lifestyle play a major role in health and curing 
diseases. 
 According to Siddha system, siddhars defined 96 principles as the constituents 
of the human being. In that PANCHABOOTHAM are the basic elements which are 
included as first section of 96 thathuvams in each and every bit of all the physical and 
subtle bodies i.e the human body and the universe. They are Aagayam (space), Kaal 
(air), Thee (fire), Neer(water), Mann(earth).The physiological function of the human 
body is mediated by VATHAM, PITHAM, KAPAM i.e three Uyir Thathukal formed 
by the combination of five basic elements.When the normal equilibrium of the three 
humors vatham,pitham and kapam were disturbed disease is caused. 
The first phase in human life is attributed to vatham, the middle phase to 
pitham, and the last phase to kapam. Thus the three humours are said to occupy the 
lower, middle and upper parts of the body respectively and maintain their integrity 
and function. The Siddha medicine has been claimed to revitalize and rejuvenate the 
metabolic dysfunctions in organs that cause the disease and maintains the bio-
regulating factors namely Vatham, Pitham, Kapam. The seven physical constituents 
UDAL THATHUKAL such as Saaram(plasma), Seneer(blood), Oon(muscle), 
Kozhuppu(adipose tissue), Enbu (bone),  Moolai(bone marrow),  Sukkilam(semen). 
         In yugi vaidhiya chinthamani- 800, urological disorders are classified into two 
categories such as 
1) Neerinai perukkal noi – where the urination will be excess . 
2) Neerinai arukkal noi – where the urine output will be reduced . 
The disease KALLADAIPPU is placed under Neerinai Arukkal noi. One of 
the works of yugi munivar, Kalladaippu is dealt under the chapter KALLADAIPPU 
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ROGAM NITHANAM. Yugi documented the sequential order of dissemination of 
knowledge of Kalladaippu from lord shiva to till yugi for the benefit of the people 
living in the world. 
 Urolithiasis is the process of forming stones in the kidneys, bladder, and or 
urethra. It is the most common disease of present society due to modern life style, 
abnormal diet habits, and low fluid intake. Most stones formed due to a combination 
of genetic and environmental factors. The diagnosis of calculi can be confirmed by 
ultra sound examination, urine & blood test are also commonly performed. 
 Several drugs and medicines are available for treating KALLADAIPPU NOI. 
However, clinical trials on the treatment of Kalladaippu noi have not yet been 
undertaken the medicine “NERUNJI VER KUDINEER” (Internal), it has to mention 
AATHMARATCHAMIRTHAM ENNUM VAIDHYA SARASANGIRAGAM 
(Pg.no.349) text book. It is well known for its diuretic and lithotriptic action in 
treating the disease KALLADAIPPU.  
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CHAPTER - II 
2.1 AIM AND OBJECTIVES 
AIM : 
  A prospective open labelled phase-II non-randomized clinical study 
about NERUNJI VER KUDINEER  in the management of  KALLADAIPPU NOI 
(urolithiasis). 
OBJECTIVES:  
A.PRIMARY OBJECTIVE  
To evaluate the therapeutic efficacy of clinical trial drug in Kalldaippu.  
B.SECONDARY OBJECTIVE: 
1. To collect the various literary evidence for Kalladaippu disease. 
2. To study the Siddha formulation of the drug  NERUNJI VER KUDINEEER in the 
treatment of KALLADAIPPU (UROLITHIASIS) for the clearance / reduction in the 
size of the calculus and clinical symptoms. 
3. To collect about the disease Kalladaippu noi with deep observation of 
aetiology, clinical features mentioned in various Siddha literatures and also in 
modern text books, diagnosis and prognosis. 
4. To confirm the diagnosis in Siddha system with the help of modern 
parameters during and after treatment in some patients.  
5. To perform urine analysis, Haematological studies and ultrasonography. 
6. 6. To determine Biochemical , Microbial analysis of the clinical trial drug. 
7. To evaluate pharmacological activity of my trial drug NERUNJI VER 
KUDINEER. 
8. To assess the safety profile of the clinical trial drug. 
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CHAPTER-III 
REVIEW LITERATURE 
 
3.1 IN JOURNAL REVIEW OF DRUG 
                                     Nerunji ver kudineer is a siddha polyherbal formulation 
consists of Nerunji ver, Sirupeelai ver, Sirukeerai ver and Seeragam. 
 NERUNJI VER: (Tribulus terrestris.L) 
Taxonomy (plants.usda.gov) 
Kingdom       :  plantae- 
Subkingdom :  Tracheobionta  
Superdivision :  Spermatophyta  
Division        :  Magnoliophyta  
Class           :  Dicotyledons 
Subclass      :  Rosidae 
Order         :  Sapindales 
Family       :   Zygophyllaceae  
Genus           :   Tribulus L. –Puncturevine        FIG.3.1.A. NERUNJI VER 
Species     :  Tribulus terrestris L. –Puncturevine 
 
            Tribulus terrestris is an annual herb which belongs to the Zygophyllaceae 
family.It is a  taprooted herbaceous perennial plant that grows as a summer annual in 
colder climates.The stems radiate from the crown to a diameter of about 10cm to over 
1m often branching.The are usually prostrate ,grow upward in shade or among taller 
plants.Leaves are opposite and pinnately compound. The flowers are five lemon-
yellow petals.The nutlets are hard and bear two to four sharp spines.  This plant has 
been used in traditional medicine for the treatment of various diseases for hundreds of 
decades. Saurabh chhatre et al (2014) was studies   the main active 
phytoconstituents of this plant include flavonoids, alkaloids, saponins, lignin, 
amides, and glycosides. The plant parts have different pharmacological activities 
including aphrodisiac, antiinflammatory, antimicrobial and antioxidant potential. 
T. terrestris is most often used for infertility and loss of libido. It has potential 
application as immunomodulatory, hepatoprotective, hypolipidemic, anthelmintic 
and anticarcinogenic activities.  
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SIRUPEELAI VER:  (Aerva lanata.L)  
         Taxonomy: (plants.usda.gov)                     FIG.3.1.B.SIRUPEELAI VER 
                               
Kingdom        : Plantae  
Subkingdom      : Tracheobionta  
Superdivision  : Spertophyta  
Division       : Magnoliphyta  
Class                  : Dicotyledons 
Subclass         : Caryophyllidae                 
Order              : Caryophyllales 
Family         : Amaranthaceae  
Genus            : Aerva Forssk- aerva 
Species       : Aerva lanata L.  
  
                                                                                           
FIG.3.1.C.SIRUPEELAI 
Extensive research from the last decades has revealed the applications 
of Aerva lanata (Linn) for the treatment of urinary disorders. It is a natural plant 
belonging to the family Amaranthaceae and grows in the warmer parts of India 
ascending to 1000 m.The root has a camphor like aroma. The dried flowers which 
look like soft spikes.  It is commonly known as sirupeelai in Tamil or Siddha.The 
plant is extensively used in urinary dysfunctions such as Ashmari (urinary calculi), 
Mootrakrichra (dysuria), and Mootravikara by most of the Ayurveda and Siddha 
practitioners in South India, in the name of pashanabheda. The plant bears almost 
all the characteristics similar to that of the source of pashanabheda. The primary 
phytoconstituents reported from this plant are flavonoids, tannins, 
anthraquinones, alkaloid, phenol, proteins, amino acids, and carbohydrates.In 
the traditional medicine of India the juice of crushed Aerva lanata root is used 
for jaundice therapy. Manoj Goyal et al (2001) was studies reported diuretic, 
anti-inflammatory, hypoglycemic, anti-diabetic, anti-parasitic, antimicrobial, 
hepatoprotective, anti-urolithiasis, antiasthmatic, antifertility and hypolipidemic 
properties of Aerva lanata. 
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SIRUKEERAI VER:(Amaranthus tricolor.L)    
Taxonomy (plants.usda.gov) 
Kingdom          : Plantae –Plants 
Subkingdom          : Tracheobionta  
Superdivision    : Spermatophyta  
Division      : Magnoliophyta  
Class              : Dicotyledons 
Subclass     : Caryophyllidae 
Order         : Caryophyllales 
Family        : Amaranthaceae – Amaranth Family 
Genus         : Amaranthus L.-pigweed                          FIG.3.1.D.SIRUKEERAI VER 
Species           : Amaranthus tricolor L. – Joseph`s-coat 
   Amaranthus plants are annual or short lived perennial plants. Catkin- like 
cymes of densely packed flowers grows in summer or autumn. Amaranthus plants or 
spinach, are used as food sources worldwide. Amaranthus leaves are rich in 
antioxidant compounds, which act as free radical scavengers. Oxidative stress caused 
by the aberrant production of reactive oxygen species (ROS) represents an important 
mechanism for neuronal dysfunction and cell loss in different neurodegenerative 
disorders.  The neuroprotective effects of antioxidant-containing plants have been 
extensively demonstrated in different models of neurotoxicity. However, few studies 
have investigated the antioxidant properties of Amaranthus extracts and their effect 
on the nervous system. A. tricolor extracts can significantly decrease cell toxicity 
and intracellular ROS production in SH-SY5Y cells. Interestingly, the extracts also 
significantly downregulated the expression of oxidative stress genes such as 
HMOX-1, RAGE, and RelA/ NF-κB. Amaranthus leaves may be useful for 
reducing oxidative stress and may be beneficial for age-related diseases and 
neurodegenerative disorders. (https://plants.jstor.org). 
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 SEERAGAM (Cuminum cyminum.L) 
Taxonomy (plants.usda.gov) 
Kingdom       :  Plantae – Plants 
Subkingdom :  Tracheobionta  
Superdivision :  Sprematophyta  
Division   :  Magnoliophyta  
Class         :  Dicotyledons 
Subclass     :  Rosidae 
Order       :  Apiales                                      
Family      :  Apiaceae – Carrot Family 
Genus      :  Cuminum L. – cumin                       FIG.3.1.E.SEERAGAM 
Species     :  Cuminum cyminum L. - Cumin 
  Cuminum cyminum, which is a popular spice that is used as a flavoring 
agent, is widely used in food. The cumin seeds Cuminum cyminum L. belong to the 
family Apiaceae and are consumed in large quantities by Indians.The cumin plant 
grows to 30-50cm tall and is harvested by hand.It is an annual herb with a slender, 
glabrous,branched stem.The leaves are pinnate or bipinnate with thread-like leaflets. 
The flowers are small white or pink and borne in umbels. The fruit is a lateral 
fusiform or ovoid achene 4-5 mm long, containg two mericarpes with a single seed. 
R.K. Johri et al (2011) was studies Cumin is widely used in medicine for the 
treatment of dyspepsia, diarrhea, and jaundice, as it has stomachic, diuretic, 
carminative, and antispasmodic properties . China is an important exporter of this 
commodity and also uses it in traditional medicine. The use of natural antimicrobial 
compounds is important in the control of human and plant diseases of microbial 
origin, Many natural compounds have been identified that have antimicrobial activity, 
including essential oils . 
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3.2. GUNAPADAM ASPECT OF DRUGS: 
Seria
l No 
Tamil 
Name / 
Botanical 
Name 
Part 
used 
Suvai Thanmai Pirivu Action 
1 
Nerunji ver/ 
Tribulus 
terrestris.L 
Root 
Sweet, 
Astringent 
Seetham Sweet 
Refrigerant, 
Diuretic 
2 
Sirupeelai 
ver / Aerva 
lanata.L 
Root Bitter Veppam Kaarppu 
Diuretic,  
Lithotriptic 
3 
Sirukeerai 
ver / 
Amaranthu
s tricolor.L 
Root 
 
Sweet 
Thatppam Sweet 
Stomachic, 
Febrifuge 
4 
Seeragam / 
Cuminum 
cyminum. L 
Fruits 
Sweet, 
Kaarppu 
Thatppam Sweet 
Carminative, 
Stimulant, 
Astringent 
 3.3. SIDDHA ASPECT OF KALLADAIPPU:  
                   Siddha system of medicine is an old age traditional system with unique 
properties is not only treating a disease but gives us an immense perception and 
approach to lead a healthy life. Among the various diseases, “Kalladaippu Noi” is one 
of the most common diseases. Several preventive and causative treatments are found 
in various siddha literatures for Kallaidaippu Noigal. In Siddha literature, Kalladaippu 
noi is mentioned by Yugi Munivar in “Yugi Vaidhya Chinthamani 800”. It is one of 
the urinary diseases which come under Neerinai Arukkal Noigal. 
“fQvqV!uqjeg<!G{k<jk!
fQbxq!uqvqk<Ks<!osiz<Ouil<!
fQvqje!ohVg<gozie<Ox!
fQvqje!bVg<g!ozie<Ox!
fQvqpqUmOe!ogiz<Zl<!
fQIg<gm<M!uqjegotie<X”!
.Ofib<fimz<!Ofib<!Lkz<!fimz<!.!3l<!higl<?!hg<gl<!531 
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3.3.1.OuXohbv<gt<< << << <!)SYNONYM)            
                      Achamarirogam. 
3.3.2 -bz << <<!)DEFINITION) 
 a) In “Agathiyar Gunavagadam” , kalladaippu noi is defined as below: 
“kioee<x!&k<kqvk<kqz<!fx!fxoue<X!
kr<gqbOkiI!ohicobEl<!l{z<kieh<hi!
uioee<x!sqxqbokiV!gz<ziukh<hi!
utlig!uf<KuqPl<!Ofib<g<G!kiOe!
Woee<x!n^<lvq!Ovigole<x!Ohvil<!
wtqkigg<!gz<Zgt<kie<!uqPGl<OhiK!
Ogioee<x!G{<cg<gib<!&k<kqvg<Gpzh<hi!
G{lie!&k<kqvh<jh!fQi<k<kijvg<!OgOt”!
Ogtmi!Le<!Gxqbqz<!wvqs<sz<!g{<M!
ogcbig!Oukjegt<!gim<Mlh<hi!
uitmi!sqxqbokiV!gx<gt<kiOe!
utlie!&k<kqvh<jh!Gpz<!upqh<hcbib<k<!
Oktmi!uVl<OhiK!kqOvgf<ke<eqz<!
okiqh<hK!Ohiz!bqVOukje!osb<Bl<hiV!
fitmi!gx<gt<ki!eqxr<gquqm<miz<!
fzlie!Oukjegt<kie<!kQVl<hiOv”!
ngk<kqbI!G{uigml<!hg<gl</7!
  
According to Agathiyar, Kalladaippu noi defines as “Deposition of crystals 
which look like sand followed by small size of stones which is excreted in the urine. 
Sometimes the stones obstruct in the kidney ureter, urinary bladder and urethra. When 
the stones reaching the uretheral orifice, intense burning sensation in the genital area. 
Then the stones get expelled and pain is relieved. 
3.3.3 Ofib<!uVl<!upq< << << <  (AETIOLOGY) 
a)  According to Maanmurugiyam are mentioned as, 
  gVfQvmg<gz<!uqjvbqz<!nchmz<!
! ! ! fQiqbf<kig<gz<!sqX!fQvmg<gz<!
! ! utqOfib<lqVg<G!L{Ul<!yPg<gLl<!
! ! ! gjmh<hqck<kqMkz<!OlgLkx<!hz!
! ! hq{qBxz<!wPlqju!bch<hjmbigg<!
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! ! ! gz<zjmh<Hobe<El<!gMl<hq{q!uqjtBl<!
! ! utqbK!lQxqObiM!lz<ziK!
! ! ! gVfQoviMr<!gzf<K!fQvgk<Ks<!
! ! sqXfQi<g<!gpQU!okiMk<kiZl<!
! ! ! ne<eju!gz<ozek<!kqvTole<h!!!!!!!!!!!!
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!.!lie<LVgqbl<!hg<gl</229!
 The above poem described as, 
 Trauma on testies, suppression of urine & semen 
 Derangement of humour in blood. 
 Excessive indulgence in sexual activity. 
 Inflammation of bladder. 
 Syphilis, stagnation of urine in urinary treat. 
 Dryness of semen causes formation of stones. 
 Increased intake of food that cause flatulence. 
 
3.3.4 ohiKGxq!G{r<gt<<< << <<(COMMON SYMPTOMS) 
df<kq!ke<eqEl<!nke<!gQp<!lVr<gqEl<!
uqjvfvl<!hqck<Kl<!OfiU!Okie<xz<!
sqXfQi<!ofxqbqz<!gz<Zvk<kMh<hqe<!
Liqk<K!Liqk<K!fQi<!uQp<f<kqMkz<!
gz<zK!uqzgq!fqe<xqce<!sqXfQi<!
oktqf<kqe!lR<st<!fqxk<kq!oziPkz<!
wElqju!gz<zjm!ohiKGxq!obe<h!!!
!!!!!!!!!!Ofib<!fimz<!Ofib<Lkz<!fimz<!higl<!.!3!hg<gl<!538!
!
 Gradual or sudden obstruction of flow of urine 
 unbearable pain (i.e agonizing pain) in the penis 
 Burning and scanty micturiation and Haematuria 
 Colicky pain radiating from loin to groin region, lower abdomen, 
urethera & genitalia if the calculus is irregular in shape. 
3.3.6!ujggt<<<<. (CLASSIFICATION) 
A)   In “Yugi vaidhya chinthamani 800” 
“Okie<xqmOkiI!fizqeqm!filr<Og!tib<!
SXg<gie!uikk<kqe<!gz<z!jmh<H!
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H,e<xqbOkiI!hqk<kk<kqe<!gz<z!jmh<H!
Hv{<mOkiI!sqOzm<Mlk<kqe<!gz<z!jmh<H!
kQe<xqbOkiI!okif<klir<!gz<z!jmh<H!
Okgk<jkh<!hx<xqOb!sqxqK!gizl<!
kie<xqOb!szh<jhbqz<!uf<kq!pqf<K!
sVuqOb!zqr<gk<kqx<!xvqg<Gf<!kiOe”!
!!!!!!!!!B,gq!juk<kqb!sqf<kil{q!himz<!839?!hg<gl<!395!
 The above poem mentioned that Kalladaippu noi is classified into four types. 
They are: 
1. Vali Kalladaippu  
2. Azhal Kalladaippu 
3. Iyya Kalladaippu 
4. Mukkutra Kalladaippu 
Vali Kalladaippu: 
“jupj;J ehgpf;F RUf;fkha; Fw;wpr; 
rykye;jhd; tPohkw; wk;g khfp 
tupj;JNk ypq;fj;jpy; typA khfp 
kUtpaNjhH nghj;jpnayhQ; Rue;J fl;b 
jphpj;jpNa fpilf;nfhlhg; gpul;lyhfpj; 
Njk;gpNa %r;Rkha; tapW Kg;Gk; 
cupj;jNjhH rijNghy ctHg;G khFk; 
Xq;fpaNjhH thjf;fy;y ilg;G jhNd”!!!!!!!!!!
!!!!!!!!!B,gq!juk<kqb!sqf<kil{q!himz<!83:?!hg<gl<!395!
 Acute pain felt just below the umbilical region and penis. Scanty 
micturition obstruction of urine flow. Sometimes mucous discharge in urine, patient 
unable to sit. 
Azhal Kalladaippu 
“njmh<higqs<!szf<kiE!lVu!zigq!
nbr<gis<sqs<!osiVgqeix<!OhiOz!gi[l<!
Hjmh<high<!ohix<xqobr<!Gl<H!Pg<gligqh<!
H,m<Mh<Ohiz<!hqGuigqh<!hqvm<m!ziGl<!
ljmh<higq!dkqvfqx!libg<gz<!zigq!
uf<kpqf<K!zqr<gk<kqz<!lim<cg!ogit<Tl<!
Gjmh<higqg<!Gx<xzib<g<!%s<szigqg<!
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Gkm<MOl!hqk<kg<gz<!zjmh<H!kiOe”!
!!!!!!!!!!!!!!!!!!!!!!B,gq!juk<kqb!sqf<kil{q!himz<!841?!hg<gl<!396!
It is characterized by reduced urine output with characteristic burning 
sensation (similar to introducing a root hot iron needle into the urethera) Excretion of 
small blood stained stones. Causing pricking pain & tenderness. 
Iyya Kalladaippu 
“kiei!okih<HtqOz!uqz<Z!Ohizs<!
szqbilx<!Svf<KOl!sx<Ox!Gx<Xl<!
Weie!giOziM!jggt<!sf<K!
-Mh<Hkie<! Gjms<szi! bqsqU! gi[l<! Oueie!
zqr<gk<kqe<!ou{<jl!ke<eqz<!
uqxuqoxe<! OxgMh<higq! uqbIjubiGl<! Okeie!
ouTh<Hg<gz<!sqXgz<!zigqs<!
sqg<gzib<!uf<kqxr<GR<!Osm<hf<!kiOe”!
!!!!!!!!!!!!!!!!!!!!!!!!!!B,gq!juk<kqb!sqf<kil{q!himz<842!hg<gl<!396!
!
It is characterized by excruciating pain in the umbilical region.  Pain in the joints 
of upper and lower extremities. Profuse sweating and expulsion of smell white coloured 
stones in the urine. 
Mukkutra Kalladaippu 
“uf<kqxr<Gl<!fQIk<kijv!bcbqx<!xiEl<!
liuVk<k!L{<migq!uzqB!ligq!
ofif<kqxr<gq!fQIkiE!lVuq!hiBl<!
ofibkie!sqXl{z<!Ohiz<!ofiXr<gq!gz<zie<!
sf<kqvr<gq!fQIupqbqz<!uf<K!uQPl<!
kig<gie!sqxr<jgg<gz<!kqeolie<!Xg<G!
Kf<kqxr<gqk<!kqef<kqeL!lqpf<K!ogiz<Zl<!
okif<klir<g!zjmh<Hs<!$m<cm<!miOb!
!!!!!!!!!!!!!!!!!!!!!!B,gq!juk<kqb!sqf<kil{q!himz<!843?!hg<gl<!397!
!
Severe pain felt below the uretheral region, Irregular urine output. It is 
characterized by disintegration of stones into small like granules excreted in the urine 
and semen.            
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B) In “Noi Vilakkam” 
utqLkz<!&e<xqEf<!Okie<x!ziZl<!
gVfQi<!ke<eqx<!Okie<x!ziZl<!
! gz<zjm!fiz<ujgh<!hMole!olipqh!
According to Noi Vilakkam, Kalladaippu Noi is classified into 4 types. 
1. Vali Kalladaippu 
2. Azhal Kalladaippu 
3. Iyya Kalladaippu 
4. Karuneer Kalladaippu 
utqg<gz<< << << <zjmh<H<<< !GxqG{r<<<<gt<<<<;!
hmi<lqgh<!hMk<kz<!hx<gt<!gck<kz<!
fMr<gz<!df<kqBl<!GxqBl<!hqjskz<!
gsMgQp<!stqobiM!gpzz<!nPkz<!
sqXfQi<!Ktqk<kz<!we<hUl<!hqxUl<!
utqbqe<!gz<zjmg<!Gxqobe!olipqb!
gXk<KR<!squf<Kl<!Ljegt<!hvf<Kl<!
!!!!!!!!!!!utqbqe<!gz<zK!ucUE!ole<h!!!!!!!!!!!!!!.Ofib<!uqtg<gl<!!!!
• Tongue biting, palpitation and chills. 
• Lower abdominal colic and pain in the external genitalia. 
• Dribbling of Urine, The Stones are blackish red in colour. 
npz<<<<gz<zjmh<H!GxqG{r<gt<;< < < << < < << < < < !
“Sm<ome!fQvqbl<!lqgouh<!hqMk<kZl<!
OfikZl<!nezg<!gz<zjmg<!GxqOb!
squf<Kl<!gXk<K!lR<s!tigqBl<!
Osr<GV!ucuqz<!gz<zK!Okie<Xl<”!
!.Ofib<!uqtg<gl<!
• Burning micturition, Dysuria 
• Passing reddish black or yellow coloured stones 
Jbg<gz<zjmh<H!GxqG{r<gt<;< < < < << < < < << < < < < !
“fQvqbr<!Gk<kz<!kq{qk<kz<!Gtqk<kz<!
wElqju!Jbg<!gz<zjmg<GxqOb!
ouTk<Kl<!Okeqx!ligqB!olitqIf<Kl<!
ohVuc!Ujmk<kil<!Jbg<!gz<zjm”!
.Ofib<!uqtg<gl<!
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• Pricking pain with severe intensity while passing urine.  
•  Fever with rigors 
• White or honey coloured shining or luminant large size stone  expelled. 
gVfQIQQQ g<gz<zjmh<H!GxqG{r<gt<;< < < < << < < < << < < < < !
“fQvqbl<!Ofikz<!sqXfQI!kjmh<hmz<!
uqjvuqz<!gqMkz<!wElqju!hqxUl<!
gVfQIg<!gz<zjmg<!Gxqobeolipqh”!
.Ofib<!uqtg<gl<!
 Sudden or gradual obstruction to flow of urine  
 Excessive Vali kutram breaks the stones into small and large size crystals and 
expels along with urine, Sudden stoppage of urine stream 
 Retention of urine, abdominal pain, Loss of taste, excessive thirst. 
 
C) In “Dhanvanthiri Vaithyam  – Part II” 
1. Kallarippan 
2. Pitha ashmari 
3. Silethuma ashmari 
4. Sukkila ashmari         
Kallarippan: 
“Sk<KfQI!fitf<ke<eQx<!Sg<gqzf<ke<eQx<!sqOzx<hel<!!
hqk<klQ!KzIk<kz<!gz<zib<!hQsgqfQ!jmk<Kg<!ogit<Tr<!!
ogik<KfQ!vqx<XuQPr<!ogih<Ht<Ofi!Gml<H!giBR<!!
sqk<ki!bVsq!B{<miR<!OsIf<kgz<!ozvqh<hieiOl” 
                jd;te;jphp itj;jpak; 
It is learnt from this poem that when kabam and pitham increase, urine and 
semen dry up, resulting in the formation of stone which in turn lead to obstruction of 
urinary tract, dysuria, pricking pain in umbilicus, fever and anorexia. 
D) In “siddhar Aruvai Maruthuvam” 
Kalladaippu noi is classified into four types. 
1. Vali kalladaippu 
2. Azhal kalladaippu 
3. Iyya kalladaippu 
4. Veneer or Manal kalladaippu   
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E) In “Roga Nirnaya Saaram under Roga Nithanam” 
Ashmari rogam is classified into five types: 
1. Vatha kalladaippu 
2.  Pitha kalladaippu 
3.  Kapha kalladaippu 
4.  Sukkila kalladaippu 
6/ Swargara Ashmari or Kalladaippu rogam/!!!!!!!!!!!
F) In “Anubhava vaidhiya Devaragasiyam – I Part” 
1. Vatha ashmari 
2. Pitha ashmari 
3. Kapha ashmari 
4. Sukkila ashmari 
5. Swargara ashmari or kalladaippu rogam                         
                                     Anubhava Vaidhiya Devaragasiyam    Page-131 
 
3.3.6 SOME DISEASES ASSOCIATED WITH KALLADAIPPU NOI IN 
SIDDHA TEXT:  
dg<giv!$jz<<< !)UKKARA SOOLAI) 
“Gk<K!Lk<giv$jz!bqe<G!{f<kie<!
OgiIjubib<!uqziUkeqz<!LKgqz<!ofR<sqz<!
nk<kq!bqeqz<!fihqbqz!hielir<G!kk<kqz<!
nkqg!Ke<lir<gqsf<kie<!utIf<K!Oluqh<!
hk<Kl{x<!hMg<jgOhix<!szk<K!uivh<!
hkqofVg<gq!&k<kqvlir<!gqvqs<sq!B{<mib<k<!
kk<Ksmr<!gMh<ohMk<K!lkqg!zr<gqk<!
ktIs<sq!obiMlbg<glib<k<!kt<Tf<!kiOe”!
!!!.!B,gq!juk<kqb!sqf<kil{q!–!911!himz<!344?!hg<gl<!99!
 Excessive growth of muscles in chest region, back of trunk, umbilicus, anal 
and urethral orifice followed by stricture of uretheral orifice by sand like crystals 
blocked in urethera causes dysuria, tiredness, body pain occurs. 
3.3.7 Lg<Gx<x!OuXhiMgt<< < << < << < < : (PATHOLOGY) 
“uiBuqeiz<!lzl<!szr<gm<cMl<!
hqiqk<kqML<!hqk<kl<!OhvR<!szk<kqeiOz”!
sqk<k!lVk<Kuir<g!SVg<gl<!hg<gl<!.!265 
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Alteration in diet and lifestyle causes the vitiation of the vatha humour for 
sufficiently enough time, which can further cause the imbalance in either of the other 
two humours and hence pitham is also deranged resulting in urolithiasis. Vali is 
responsible for dryners and Azhal is responsible for the heat. This causes decrease in 
body fluids and increase in concentration of urine and thereby the crystal grows and 
aggregation takes place in the urinary passage. As (kezhnokkukal) “Abanan” one of 
the component of ten vayu, is strongly responsible to expel the deposits that will be 
automatically washed out in urine. If Abanan is not strong enough, the deposited 
material will not be expelled and pave way for renal stones. 
 
SIDDHA PATHOLOGY & SCIENTIFIC ASPECTS OF KALLADAIPPU 
 
Indiscipline in Food and Lifesytle 
 
 
           Vitiated vali      Vitiated Azhal 
 
                           Dryness   Heat 
 
   
 
 
  
 
 
More over Vatham is responsible for maintenance of 14 reflexes including 
micturition. Therefore body pain, pricking pain in external genitalia and constipation 
seen in urolithiasis (Kalladaippu) due to altered vatham humour. 
 Pitham has direct link with urine (i.e) “Pitham Siruneeril Adangum”. 
Therefore symptoms of darked yellow urine, sometimes reddened urine seen in 
Kalladaippu due to elevated pitham humour.Decreased Kapham humour prones the 
body constitution to dryness and heat. All these derangements create the alterations in 
biochemical parameters of Kidney function form the symptoms of urolithiasis 
Concentration of 
urine 
Crystallization of  
Urine 
Formation of urinary 
stones 
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3.3.8 PRINCIPLES OF SIDDHA DIAGNOSIS IN UROLITHIASIS: 
 Siddhars investigate the cause of the disease the signs and symptoms, 
complications if any and anatomical (udal kooru) changes to arrive at a diagnosis of a 
disease. They examine both the body and the disease together to arrive a conclusion 
regarding the condition or diseases.They followed two paths called “Noi naadal” in 
simple terms defined as the approach to the disease and “Noi Mudhal Naadal” which 
is determination of aetiologyof the disease. These diagnostic tools designed by 
siddhars that they can also determine the risk factor and help in early prediction of the 
illness. The following are the diagnostic methodologies of urolithiasis in Siddha. 
S.No. Thathuvams 
Affected basic 
principle 
Symptoms of Kalladaippu 
1. Uyir thathukkal (3) 
1. Vatham (10) 
Abanan 
Udhanan 
Scanty mituriation, 
Haematuria, Dysuria, 
Nausea and vomiting 
2. Pitham (5) 
 Saathagapitham 
Dysuria, oliguria 
3. Kabham (5) 
  Santhigam 
Pain present in the joints 
2. Udal thathukkal (7) 
1. Moolai (bone 
marrow) increased 
Oliguria 
2. Sukkilam (semen) 
increased 
Renal calculus 
3. Iymboothangal (5) 
1. Vayu (Air) Obstruction in genitalis 
2. Thaeyu (fire) 
Dryness, heat burning 
sensation 
3. Appu (water) Reddened urine 
4. 
Iymporial / 
Iyampulangal (5) 
1.Mei Koocherithal 
5. 
Kanmenthiriyam / 
Kanmavidayam (5) 
1. Eruvai Constipation 
6. Aasayam (5) 
1. Salavasayam Oliguria 
2. Sukkilavasayam 
Pain and burning sensation 
in external genitalis 
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7. 
Yakkai (3) (General 
characters) 
1. Vatham 
“Siruneer porumi Kaduthu 
vizhum” 
2. Pitham 
“Neerum uyarnthu 
sivappagum” 
8. Manikkadai 
9 ¼ 
“Neer kaduthu siruthu 
irangam”. dysuria and 
stranguria 
6 ¾ 
Proned to urolithiasis in 
3years of time 
9. Thinai (5) 
1. Muthuvenil 
2. Karkalam 
Affected 
10. Kaalam (7) 
1. Neithal 
2. Mullai 
Affected 
3.3.9!Ofib<!g{qh<H!Ljx< << << <  (DIAGNOSIS AND PROGNOSIS) 
 The Diagnostic methodology in siddha system in unique and it is made purely 
on the basis of clinical acumen of the physician. In “Piniyari muraimai” the following 
principles are 
1. Poriyaal arithal - Physical examination 
2. Pulanaal arithal - Clinical examination 
3. Vinaathal  - Medical History 
1. PORIYAAL ARITHAL : It means understanding by the five organs of 
perception. 
 Mei  – Ooru (somatic sense) to feel all types of sensation 
 Vai  - Suvai (taste) for knowing taste. 
 Kan  - Oli (vision) for vision 
 Mookku  - Natram (smell) for knowing the smell 
 Sevi  - Osai (sound) for hearing 
2. PULANAAL ARITHAL : It means understanding by sensing the objections. 
 Kai  - All Manocurves 
 Kal  - Walking 
 Vai  - Speaking 
 Eruvai  - Defecation 
 Karuvai  - Reproduction 
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3. VINAATHAL (Interrogation) 
 The first step in diagnosing a disease by knows their personal history of the 
patient through Interrogation. The physician should interrogate the patients name, age, 
native place, socio economic states, food habits, personal habits, present complaints, 
of history of present illness, history of past illness, through this applied eight tools of 
investigation (i.e) Envagai Thervugal . 
3.3.10 w{<ujgk<!Oki<Ugt<;< < < << < < << < < < !
! “ngk<KX!Ofijb!gvk<kil!zgl<Ohiz<!
hGk<kxquQi<!fich<!hiqsl<!.!okiGk<k!fqxl<!
gm<Mujgs<!osiz<olipq!g{<m!lz!&k<kqvl<!fi!
wm<Mujg!biZ!lxquQi<”!
.ngk<kqbi<!juk<kqb!sqf<kil{q!ou{<hi!5111!
!
“fic!hiqsl<!fifqxl<!olipquqpq!
lzl<!&k<kqvlqju!lVk<KuviBkl<”!!!!!!!!!!!!!!!!!.Okjvbi<!
“olb<Gxq!fqxf<okieq!uqpqfiuqVlzl<!jgg<Gxq”!!!!!!!!.Okjvbi<!
!
 According to Agathiyar vaithiya chinthamani venba- 4000 and saint therayar, 
the Envagai Thervugal (Eight types of diagnostics) include, Naadi(pulse), Naa 
(tongue), Niram(colour), Mozhi(voice), Vizhi(eyes), Malam(faeces), Neer(urine) and 
Sparisam (touch & palpation). 
 
In “Gunavagada Naadi” about the Envagai Thervugal as following. 
“kv{qBt<t!uqbikq!ke<je!bm<mir<gk<kiz<!
kieqbxqb!Ou{<MuK!ObOki!oue<eqz<!!
kq{qbOkiI!ficg{<gt<!sk<kk<OkiM!
Okgk<kqeK!hvqsl<!uV{l<!fig<G!
bqv{lz!&k<kvliuqjug!otm<Ml<!
bqkl<hmOukie<!hiIk<K!Gxqh<Hr<g{<M!
hv{Vtiz<!ohvqObiIgt<!hikl<!Ohix<xq!
h{<H!kuxilz<!h{<ckR<!osb<uQOv”!!! ! !
!!!!!!!!!!!!!!!!!!!!!!!!!G{uigm!fic!hg<gl<!< << << < .!23:!
!
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 In “Agathiyar vaithya vallathy” to apply the envagai thervugal for 
diagnosis of the disease. 
“okiGg<gZx<x!nm<muqk!hvQm<js!ke<je!
Kzg<gLXl<!h{<ckOv!oktqukigh<!!
hMg<giqb!ficjb!fQ!hqck<Kh<hiV!!
hgIgqe<x!uiIk<jkjbh<!hiI!fiju!hiV!!
uGg<gvqb!Okgole!okim<Mh<!hiV!!
utlie!svQvk<kqe<!fqxk<jkh<!hiV!!
sgqg<gvqb!lzk<jkh<!hiV!szk<jkh<!hiV!!
siIf<k!uqpqkjeh<!hiIk<K!oktquib<!giO{!!
fQcb!uqpqbqeiZl<!fqe<x!fig<Gxqh<hqeiZl<!!
uicb!OleqbqeiZl<!lzoliM!fQvqeiZl<!
$cb!uqbikq!ke<jes<!Sgl<ohx!nxqf<K!osiz<Oz”!
ngk<kqbI!juk<kqb!uz<zikq!
!
1. Naadi (pulse) 
 Naadi is nothing but the manifestation of the vital energy that sustains the life 
within our body. It plays an important role in “Envagai Theruvugal” and it has been 
considered as foremost thing in assessing the prognosis and diagnosis of various 
diseases. Any variations occur in three humours it is reflected in naadi. These three 
humours organize, regularize and integrate basic functions of the human body. So, 
Naadi serves as a good indicator of all aliments. 
“uqPGl<!sqzOfvl<!uqMhm<M!fQOviMl<!
yPgqb!uiBUl<!yKr<gqeiz<!OfigiK!
uPgqb!lf<kk<kiz<!uiBuf<Ok!Hgqz<!
gPlq!LkqIf<kqMl<!gz<ozvqh<H!NGOl”!
!
kqV&zI!gVg<gqjmjuk<kqbl<!711!
 The above line mentioned that the Vatham and Mantham combined together, 
Kalladaippu noi may occur. 
“njxf<Okil<uik!OvigqBmz<!
npxg<{<LgLl<!hz<lzLl<!
fqjxf<k!uqpqbqz<!fQI!ucBl<!
fQ{<m!fiU!gXk<kqmUl<!
kqjxf<kLt<tib<!kieqVg<GR<!
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sqX!fQI!ohiVlq!gMk<K!uVl<!
djxf<k!fQVr<gVgVk<K!
Ljxbib<!OvigL!L{<miOl”!
!!!!!!!!!.Ofib<!fimz<!Ofib<!Lkz<!fimz<!kqvm<M–!Lkz<!higl<?!hg<gl<!.!276!
!
“OluqbuikR<!osb<Bl<!
G{f<kje!uqVl<hqg<OgT!
kiuqb!ubqX!lf<kR<sf<Kgiz<!ohiVk<K!Ofiuil<!
Osuqb!kiK!fisR<!
sqXk<Kme<!sqX!fQIuQPl<!
giuqbr<!g{<{qeiOt!
lzlK!gVgqg<!gi[l<”!!!!!!!!!!
!!!!!!!!!!!!!!!!!!!!!!!!!!!.-vk<kqe!SVg<g!fic!
!
The above two poems describes that aggravation of Vatham naadi produces 
symptoms of Kalladaippu noi. 
“w{<{qb! uikolie<Xl<! hqk<klqv{<! omPf<kigqz<H{<o{e!
Bml<H! Ofiuil<! Hjgobp! obvqBl<! ofR<S! kq{<{lib<!
fiuv{<M! sqXk<KfQIg<! gMk<K! uqPl<! n{<{uiI!
djvf<kU{<jl!biBV!Okue<kiOe”!
ke<uf<kqvq!juk<kqbl<!.!Lkz<!higl<?!hg<gl<!22!
!
The above line mentioned when Vatham and Pitham combined together which 
may result in Kalladaippu noi. 
2. Sparism (Touch) 
 In Sparism the temperature of skin (Thatpam-cold or veppam-heat),  
smoothness, roughness, sweating, dryness, hard patches, chillness, greasy, swelling 
abnormal growth of organs and tenderness can be felt. 
 On examination in Kalladaippu patients tenderness over the lower abdomen, 
renal angle and lumbar region can be felt, sometimes swelling can be felt (may be due 
to hydronephrosis) 
3. Naa (Tongue) 
 On examination the physician is expected to observe the features of the tongue 
and its colour, shape, size, coating, moisture, movement, ulcer, fissure, crust. In 
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Kalladaippu noi, of the patient suffers from constipation, the tongue would seen to be 
coated. In karuneer kalladaippu noi the patient has loss of taste sensation. 
! “gVfQi<gz<zqe<!utq!sqef<okPf<K!
! Sjuogmz<!outqX!lXh<H!fQi<Oum<jg”!
.Ofib<!uqtg<gl<!
4. Niram (Colour)!
            The physician is required to observe the colour of the skin, 
conjunctiva, tongue, nail bed and hair etc… and make a note if any abnormal colour 
changes. 
 Vali udal - Black colour 
 Azhal udal - Yellow or red colour 
 Iyya udal - White or yellow colour 
 In Kalladaippu noi body complexion depends upon the body constitution, 
pallor of the body is observed in Sukkila ashmari. 
“sqg<gqfQi<!uqpi!lzr<Og!l{z<uqPl<!ouTg<Gf<Okgl<!
! lqg<G{R<!Sg<gqziS!liqbsik<!kqbole<OxiOki”!
ke<uf<kqiq!juk<kqbl<!.!3!higl<?!hg<gl<!21 
5. Mozhi (Speech) 
 By examining, the mozhi (speech) the vaious characters can be noted such as 
hoarseness, histery voice, slurring speech, va 
rious disorders of speech such as dysarthria can be noted. In kalladaippu noi, there is 
low pitch voice due to agonizing pain of lower abdomen and burning micturition. 
6. Vizhi (Eye) 
 On examine the colour of eye like pallour, reddish or yellowish discolouration 
and characters like dryness, odema, lacrimation any visual disturbances. 
7. Malam (Stools) 
 It is necessary to examine the nature (consistency) colour, quantity, hard stools 
(or) loose stools presence of blood and froth and also pain during defecation. 
8. Moothiram (Urine) 
 Urine examination is one of the good diagnostic tools when compared to other 
Envagai thervugal. 
“kvqk<K!fihqg<G!SVg<glib<!Gx<xqs<!
szlzf<kie<!uQpilx<!xl<h!ligq!
uvqk<KOl!zqr<gk<kqz<!uzqB!ligq!
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lVuqbOkiI!ohik<kqobziR<!Svf<K!gm<c!
kqiqk<kqOb!gqjmg<ogimih<!hqvm<mzigqk<!
Okl<hqOb!&s<Slib<!ubqX!Lh<Hl<!
dvqk<kOkiI!sjkOhiz!duIh<H!liGl<!
Yr<gqbOkiI!uikg<gz<z!jmh<H!kiOe”!
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!ke<uf<kqiq!juk<kqbl<!himz<!83:?!hg<gl<!395!
! In Kalladaippu Noi, urine was in high concentrate and sometimes it contains 
blood stains (Haematuria). Patient having loin to groin pain and burning pain with 
glans penis while passing urine or end of the urine. Sometimes patients having severe 
abdominal pain, urine is bitter taste or aromatic odour in nature. 
fQi<g<Gxqh<H!sqxh<H;Q < < < <Q < < < <Q < < < < !
“kIg<gsik<kq!kqvqg!tiOeiI!
kr<gtqx<!OxIf<K!fic!
uIg<glil<!fic!ke<eqz<!
uVuK!lbg<gl<!ole<Ox!
dx<xfQIh<!hvQj]!hib<f<Ok!
Bjvk<ke!iqkx<G!Ofvib<!
lx<oxiV!uqkqF~!zqz<jz!
lVk<Ku!gjzuz<OZiIg<Og”!
sqk<k!lVk<Kuir<gs<!SVg<gl<?!hg<gl<!679!
 In order to sheet off the ambiguity in the diagnosis of disease through pulse 
perception. The exponent have charted out a method called Neerikuri – an in 
camparable method of diagnosis. 
sqXfQiqe<!ohiKG{l<!;Q < <Q < <Q < < !
! “uf<kfQVg<!giqobjm!l{l<!Fjv!wR<sOze<!
! jxf<kqb!ZTju!bjxGK!LjxOb”!
sqk<k!lVk<Kuir<gs<!SVg<gl<?!hg<gl<!621!
 The above line mentioned that the five parameters should be examined in each 
urine sample. 
1. Niram (Colour) 
2. Edai (Specific gravity) 
3. Nurai (Froth) 
4. Naatram (Smell) 
5. Enjal (Deposits) 
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a) Niram (colour) 
 Nira thogai: 
“hQkl<!osl<jljhr<!gVjl!ou{<jlobe<!
Oxikr<!ogiPjljb!obik<KG!fQOv!
sqk<k!lVk<Kuir<gs<!SVg<gl<!hg<gl<!621 
 The above poem reveals that urine colour as follows. 
1. Yellow   2. Red,  3. Green  4. Black, 5. White. 
gz<zjmh<H!fQiqe<G{l<!)< < Q < << < Q < << < Q < < Colour indicating urinary stone*!;!
“kQh<Hziz<!gPfQIs<!osbozeqx<!G{<cg<!
gib<k<KIh<!hzk<kiz<!gkqk<k!fQvilk<!
KIh<hzg<!ghLl<!OsiiqBl<!ogikqh<Hxh<!
hx<hg!zigh<!jhjbh<!hkqf<Ok”!
sqk<k!lVk<Kuir<gs<!SVg<gl<?!hg<gl<!631!
 The colour of the urine look like decomposed flesh cleaned water indicates the 
presence of kidney stones. 
b) Edai (specific gravity) 
“lqgk<kch<!Hllqgk<!OkxZl<!-e<oxeqz<!
Sgk<jkk<!kVl<olb<s<!ShiufQI!fe<Ox”!
sqk<k!lVk<Kuir<gs<!SVg<gl<?!hg<gl<!639!
Urine which is not thick it is considered to be healthy one. 
c) Nurai (Froth) 
“hf<kolb<h<!hjsbqt!gh<hMl<!hVuk<!
kf<kIh<!H,klib!fqzLk<!kqvk<kqz<!
sl<hf<kh<!hMl<!kkq!Fjvh<!HeOz”!
sqk<k!lVk<Kuir<gs<!SVg<gl<?!hg<gl<!639!
In normal condition, urine is frothy in nature. When these is reduced froth in 
the urine it indicates derangement of vali, Azhal, Iyyam. 
d) Naatram (smell) 
“gi{qkqz<!sQPl<!gzf<kqpq!l{Lxqe<!
gVh<hfi!hqgTTr<!gilfitk<KTl<!
uqv{Le<!ce<Oxe<!wb<Kl^<!lvqbz!
kqVk<kOz!kq{<{!olelek<!Ke<Oe”!
sqk<k!lVk<Kuir<gs<!SVg<gl<?!hg<gl<!62:!
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 The above poem states that foul colour with pyuria is observed in patient with 
urolithiasis is associated with secondary Urinary tract infection. 
e) Enjal (Deposits) 
“fiIk<kq!fQIhiz<!Ohiz!
fjuBx<xr<!gqpqB!lieiz<!
livx<h!Lx<x!fQvq!
zcl{<cg<!gqmf<f!kieiz<!
hivqf<k!olPG!lir<gib<!
hx<xqb!gz<zqeiOz!
sQVx<x!osb<jg!obe<X!
okvqUxosh<h!ziOl!
sqk<k!lVk<Kuir<gs<!SVg<gl<?!hg<gl<!686!
 The colour of the urine excreted looks like curd water or milk and the 
presence of white colour and sand like deposits in urine indicated stones in the 
kidney. 
3.3.22ofb<Gxq<<< !)GENERAL EXAMINATION) 
“nVf<Kli!xqvkLl<!nuqOvi!klkib<!
n0gz<!nzIkz<!ngizu,{<!kuqIf<kpx<!
Gx<xt!uVf<kq!dxr<gq!jugjx!
Ncg<!gzsk<!kiuqob!giKohb<!
okiVL%Ik<!kg<gjzg<!Gm<hM!fQvqe<!
fqxg<Gxq!ofb<Gxq!fqVlqk<kz<!gmOe”!
sqk<k!lVk<Kuir<gs<!SVg<gl<?!hg<gl<!61:!
Preparation of the patient:  
On the day before the urine examination for Neikuri, the patient should be 
advised to take balanced diet and quantity of food must be proportionate to his 
appetite. In addition he/she should have a good sleep. 
Method: 
 After waking up in the early morning, urine should be collected in a glass 
container and must be examined with in 1 ½ hours. Then a drop of gingely oil should 
be added through the side of the container without any disturbance. The nature of 
neikuri should be noted under direct sunlight. 
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Observation : 
    Vatha Neer: 
“nvoue!fQ{<ce<!n0Ok!uikl<”!
sqk<k!lVk<Kuir<gs<!SVg<gl<?!hg<gl<!643!
 In the drop of oil, lengthening like a snake it indicates vathaneer. 
Pitha Neer: 
“NpqOhix<!hvuqe<!n0Okhqk<kl<”!
sqk<k!lVk<Kuir<gs<!SVg<gl<?!hg<gl<!644!
 In the drop of oil spreading like a ring, it indicates pitha neer. 
KabhaNeer: 
“Lk<okik<K!fqx<gqe<!olipq!uke<!ghOl”!
sqk<k!lVk<Kuir<gs<!SVg<gl<?!hg<gl<!645!
! In the drop of oil, remaining as that of pearl, it indicates kapha neer. 
 
Thontha neer: 
“nvuqzizqBl<!Npqbqz<!<nvUL<!
nvuqe<Lk<Kl<!Npqbqz<!Lk<Kl<!
Okix<xqz<!okif<k!Okimr<gtiOl”!
The thontha neer appears as a combination of the above pattern. 
Mukkutra neer: 
The drop of oil immersing in to the urine, indicates Mukkutraneer. 
sik<kqbl<?!nsik<kqbl<< < < << < < << < < < (PROGNOSIS) 
“$m<cm<m!sik<kqbk<jk!osiz<zg<!Ogtib<!
STg<giGl<!uiik<kqe<!gz<zjmh<H!
H,m<cm<m!hqk<kk<kqe<!gz<z!jmh<Hh<!
Hgpie!Osm<Mlk<kqe<!gz<z!jmh<H!
!!!!!!!!!!!&m<cm<m!-K&e<X!lsik<b!ligq!
Ljebie!lVf<Kgtqx<!osl<jl!biGl<!
Okim<cm<m!okif<klir<!gz<z!jmh<Hk<!!
okiMSxOu!ogiz<ZlqK!$m<sf<!kiOe”!
!! ! ! ! ! ! B,gq!juk<kqb!sqf<kil{q!911!
!
!
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 According to YUGI VAIDHIYA CHINTHAMANI-800 Vatha, Pitha, Kabha 
kalladaippu are curable and preventable, but Mukkutra Kalladaippu is not curable. 
 According to ROGA NIRNAYA SAARAM under Rogam Nithanam, symptoms 
of kallaidaippu noi like scrotal swelling and anuria are not curable. 
 
3.3.12 LINE OF TREATMENT ADVOCATED AS PER THE SIDDHA 
PRINCIPLES: 
 In Urolithiasis, vatham and pitham are the two predominant factors which is 
responsible for the predisposition of stone formation, it is associated with heat and 
dryness. So the treatment should be planned towards the settlement of the affected 
humours as primary goal and secondary objective with medication towards the target 
action at specific sites and tertiary target to strengthen the system for the prevention 
of the disease. 
 As the above mentioned poem, purgation should be given to all patients as per 
their by condition. Kazhichal marunthu (purgatives) : Decoctions and mediated ghee 
with coolant properties are used to promote purgative to cleanse the colon bring about 
a balance of the impaired “TRIDHOSHAM”. 
3.3.13 DIET: 
 Diet plays an important role in both prevention and protection of the body 
from stone diseases. Diet can contribute to the actiology, management or prevention 
of recurrence of kidney stone, because dietary ingredients and fluid intake influence 
the volume, PH and solute concentration of urine. 
 In urolithiasis, the diet should on with the target to promote the urination, 
washout the urinary bladder and to expel the small stones. 
d{U!hpg<gupg<gr<gt<;< < < << < < << < < < !
d{<{g<%cbju;< << << < !
 GVju?!l{g<gk<jk!niqsq!bizig<gqb!OsiX!d{<{!Ou{<Ml</!
 hii<zq!niqsqg<gR<sq?!-tfQi<!nVf<kUl</!
 Lt<tr<gq?! uijpk<k{<M?! nujvg<gib<?! H,s{qg<gib<?! Sjvg<gib<?Ogvm<?!
ou{<jmg<gib<!Osi<g<g!Ou{<Ml</!
 ki<H,s{q?!hh<hitq?!ogib<bi?!wZlqs<js!Osi<g<gzil</!
 hsjzg<gQjv?!gisqeqg<gQjv?!gQjvk<k{<M?!out<tiq!uqjk!d{<{Ul</!
!
!
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kuqi<g<g!Ou{<cju< < << < << < < ;!
 kg<gitq?!Lm<jmOgi <^?!gizqh<tui<?!dVjtgqpr<G?!gitie</!
 hiz<?!gihq?!C?!lKhiel<?!hkh<hMk<kh<hm<m!hier<gt<!nVf<kg<%miK/!
 Lm<jm?!J <^gqiQl<?!sig<Ozm<!kuqi<g<gUl</!
Advice :  
1. Patient should drink large quantity of water (4 litre/day)  
2. Patient should reduce salt intake 
3. Regarding prevention “Anubhava Vaidhya Deva ragasiyam” states the one 
should not suppress the excretion of moothiram (Urine) and sukkilam 
(Seminal fluid) is most predisposing cause for Kalladaippu noi. 
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3.4 MODERN ASPECT 
 3.4.1 URINARY SYSTEM 
 The urinary system also known as the renal system. The urinary system's 
function is to filter blood and create urine as a waste by-product. The organs of the 
urinary system include the kidneys, renal pelvis, ureters, bladder and urethra. The 
kidney and urinary systems help the body to eliminate liquid waste, and to keep 
chemicals, such as potassium and sodium, and water in balance and regulate blood 
PH. Following filtration of blood and further processing, wastes (in the form of urine) 
exit the kidney via the ureters, tubes made of smooth muscle fibres that propel urine 
towards the urinary bladder, where it is stored and subsequently expelled from the 
body by urination (voiding) through urethera.  
FIG.1.FRONT VIEW OF URINARY TRACT 
 
3.4.2. UROLITHIASIS  
                         Urolithiasis is the formation of stones (calculi) anywhere in the 
urinary tract in the renal pyelocalyceal system, ureter, bladder, and urethra). It is the 
third most common urinary tract disease in humans. According to localization, there 
is renal lithiasis (nephrolithiasis), ureter lithiasis (stones in the tubules through which 
urine flows from kidneys to the bladder), bladder lithiasis and urethral lithiasis (stones 
in the tubule ejecting urine from the bladder outwards).   The development of the 
stone is related to decreased urine volume or increased excretion of stone –forming 
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components such as calcium, oxalate, urate, cystine, xanthine, and phosphate. It is 
estimated that approximately 2% of the population experiences renal stone disease at 
some time in their life with male-female ratio of 2:1. The peak incidence is observes 
in 2nd and 3rd decades of life. 
 
FIG.2.KIDNEY STONE DISEASE 
 
3.4.3 EPIDEMOLOGY: 
Hereditary: 
 For patients with kidney stones caused by any one of the following rare 
conditions: 
 Hypercalciuria 
 Cystinuria 
 Hypocitraturia 
 Enteric hyperoxaluria (EH) 
 APRT deficiency 
 Primary hyperoxaluria (PH) 
Age: 
 The peak incidence of kidney stone in the age of 20-60 years. 
Sex: 
 Mostly kidney stone affected men than women. 
Geographical influence: 
 The prevalence of urinary calculi is higher in those who live in high attitude, 
high temperature, and tropical areas. 
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Climate and seasonal factors: 
 Incidence of urinary calculi and aggravation of symptoms are noted during 
summer months. 
Nutrition: 
 Lack of liquid foods 
 Excessive sodium intake 
 Increased meat from beef, pork, poultry, fish and seafood 
 Citrate fruits and vegetables 
 White sugar 
Dehydration: 
 Not drinking enough water each day may increase risk of kidney stones people 
who live in warm climates and those who sweat a lot may be at higher risk than 
others. 
FIG.3.PREDISPOSING FACTORS FOR URINARY STONES: 
 
RISK FACTOR RELATED TO OTHER DISEASE: 
o Parathyroid disorders 
o Gout 
o Urinary 
o tract infection 
o Bed ridden patients 
o Previous catherization 
FACTORS RELATED TO TAKING DRUGS:                   
 Antacids 
 Vitamin C 
 Aspirin 
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3.4.4 AETIOLOGY 
1. CALCIUM STONES: 
Aetiology of calcium stones is variable. 
1.Hyperparathyroidism 
2.Inflammatory bowel disease 
3.Dent disease 
4.Gastric bypass surgery  
5.Diabetes mellitus 
6.Over weight. 
2. MIXED (STRUVITE) STONES: 
Struvite stones account for 15% of renal calculi.Usual organisms include.   
• Proteus 
• Pseudomonas  
• Klebsiella species 
3. URIC ACID STONES: 
Uric acid stones are frequently formed in cases with hyperuricaemia and 
hyperuricosuria such as due to primary gout or secondary gout due to 
myeloproliferative disorders (e.g. in leukaemias), especially those on chemotherapy, 
and administration of uricosuric drugs (e.g. salicylates, probenacid). Other factors 
contributing to their formation are acidic urine pH (below 6) and low urinary volume. 
3. CYSTINE STONES: 
Cystine stones are associated with cystinuria due to natural substance 
called ‘cystine’ leak into urine. 
4. OTHER CALCULI: 
Are caused due to inherited abnormality of enzyme metabolism. 
   3.4.5 TYPES OF URINARY STONES:  
 There are four types of urinary calculi, they are 
1. Calcium type of stone-75% 
2. Mixed (struvite) type of stone-15% 
3. Uric acid type of stone-6% 
4. Cystine type of stone-2% 
5. other types-<2% 
 
33 
 
                                    Figure.3.4.5.TYPES OF URINARY STONES 
 
 
1. CALCIUM STONES: 
Most kidney stones are made up of calcium compounds, especially 
calcium oxalate. Calcium stones are the most common comprising about 75% 
of all renal calculi.the different type of calcium stones are calcium oxalate and 
calcium phosphate.  
2. MIXED (STRUVITE ) STONES: 
About 15% of urinary calculi are made of magnesium-ammonium-
calcium phosphate, often called struvite; hence mixed stones are also called as 
struvite stones' or' triple phosphate stones. Struvite stones are yellow-white or 
grey. They tend to be soft and friable and irregular in shape. 'Staghorn stone' 
which is large, solitary stone that takes the shape of the renal pelvis where it is 
often formed is an example of struvite stone. They can also be called infection 
stones if they occur with kidney or urinary tract infections. These types of 
kidney stones sometimes are also called staghorn calculi if they grow large 
enough. 
    3.URIC ACID STONES: 
Uric acid stones are one of four major type of kidney stone. Uric acid 
stones are smoothing, yellowish-brown, hard and often multiple. On cut 
section, they show laminated structure.Uric acid stones form when the levels 
of uric acid are too high. 
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4. CYSTINE STONES: 
Cystine stones comprise less than 2% of urinary calculi. Cystine   stonesare 
small, rounded, smooth and often multiple. They are yellowish and waxy. They 
occur in both men and women who have the genetic disorder cystinuria. 
5. OTHER CALCULI: 
Less than 2% of urinary calculi consist of other rare types such as Xanthine stones. 
  Drug induced stone 
                      These constitute the rare forms of stones which are drug induced forms 
that results from various drugs like indanavir, triamterine, flouroquinolones, 
primidone, tetracyclines, magnesium trisilicate and sulfonamides. In addition to this, 
other drugs like calcitriol, corticosteroids, furosemide and acidifiers can predispose 
the individual to hypercalciuria induced calcium uroliths.  
                           In other cases like ascorbic acid and allopurinol therapy, there exist 
implications of hyperoxaluria and hyperxanthuria induced lithogenesis . Topiramate, a 
new anti epileptic drug also implicate the calcium uroliths by its renal tubular acidosis 
induced by its carbonic anhydrase enzyme. HIV-positive patients are more prone to 
develop these drugs induced stones when they are treated with lithogenic drugs like 
indinavir and sulfamides (sulfamethoxazole and sulfadiazine). 
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3.4.6 PATHOGENESIS OF STONE: 
   FIG.4.PATHOGENESIS OF KIDNEY STONE 
 
Urinary stones usually arise because of the breakdown of a delicate balance 
between solubility and precipitation of salts. The kidneys must conserve water, but 
they must excrete materials that have a low solubility. These two opposing 
requirements must be balanced during adaptation to diet, climate, and activity. The 
problem is mitigated to some extent by the fact that urine contains substances that 
inhibit crystallization. These protective mechanisms are less than perfect. When the 
urine becomes supersaturated with insoluble materials, because excretion rates are 
excessive and/or because water conservation is extreme, crystals form and may grow 
and aggregate to form a stone. 
SUPERSATURATION: 
CALCIUM KIDNEY STONES: 
A solution in equilibrium with crystals of calcium oxalate is said to be 
saturated with respect to calcium oxalate. In these patients urine organic molecules 
most weaken links between supersaturation and crystal formation.As a consequence, 
clinical supersaturation use depends on the principal maxim. 
URIC ACID KIDNEY STONES 
           By contrast supersaturation links so strongly to uric acid kidney stones we 
need no maxims.Reducing supersaturation below 1 prevents the stones. Nor does 
anyone  doubt that urine pH controls uric acid supersaturation.No one will attempt a 
formal trail of potassium citrate – which raises urine pH – for uric acid kidney stones. 
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CYSTINE KIDNEY STONES: 
            This organic crystal forms when urine is supersaturated with cysteine because 
transport defects in the kidneys lead to excessive excretion.Though not easy to 
measure commercially available urine cystine supersaturation gives reliable results, 
even despite thiol binding drugs. 
CRYSTALLIZATION: 
When urine supersaturation exceeds the upper limit of metastability, crystals 
begin to nucleate. Cell debris and other crystals present in the urinary tract can serve 
as templates for crystal formation, a process known as heterogeneous nucleation. 
Heterogeneous nucleation lowers the level of supersaturation required for crystal 
formation. Once formed, crystal nuclei will grow in size if urine is supersaturated 
with respect to that crystal phase. Multiple crystals can then aggregate to form a 
kidney stone. 
In order for a kidney stone to form, crystals must be retained in the renal 
pelvis long enough to grow and aggregate to a clinically significant size. The 
mechanism of crystal retention has been a matter of much debate. Recent studies have 
shown that common calcium oxalate kidney stones form as overgrowths on apatite 
plaques in the renal papillae. These plaques, called Randall's plaques, provide an 
excellent surface for heterogeneous nucleation of calcium oxalate salts. The Randall's 
plaques begin in the deep medulla in the basement membrane of the thin limb of the 
loop of Henle and then spread through the interstitium to the basement membrane of 
the papillary urothelium. If the urothelium becomes damaged, the plaque is exposed 
to the urine, and calcium oxalate crystallization and stone formation begins. 
INHIBITORS OF CRYSTAL FORMATION: 
Urine contains potent inhibitors of nucleation, growth, and aggregation for 
calcium salts. Inorganic pyrophosphate is a potent inhibitor that appears to affect 
formation of calcium phosphate more than calcium oxalate crystals. Citrate inhibits 
crystal growth and nucleation, although most of the stone inhibitory activity of citrate 
is due to lowering urine supersaturation via complexation of calcium. Other urine 
components such as glycoproteins inhibit calcium oxalate crystallization. 
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1. CALCIUM STONES: 
The mechanism of calcium stone formation is explained on the basis of 
imbalance between the degree of super saturation of the ions forming the stone and 
the concentration of inhibitors in the urine. Most likely site where the crystals of 
calcium oxalate and/or calcium phosphate are precipitated is the tubular lining or 
around some fragment of debris in the tubule acting as nidus of the stone. The stone 
grows, as more and more crystals are deposited around the nidus. A number of other 
predisposing factors contributing to formation of calcium stones are alkaline urinary 
pH, decreased urinary volume and increased excretion of oxalate and uric acid. 
2. MIXED (STRUVITE) STONES: 
Struvite stones are formed as a result of infection of the urinary tract with 
urea-splitting organisms that produce urease. 
3. URIC ACID STONES: 
The solubility of uric acid at pH of 7 is 200 mg/dl while at pH of 5 is 15 
mg/dl. Thus, as the urine becomes more acidic, the solubility of uric acid in urine 
decreases and precipitation of uric acid crystals increases favouring the formation of 
uric acid stones. Hyperuricosuria is the most important factor in the production of uric 
acid stones, while hyperuricaemia is found in about half the cases. 
4. CYSTINE STONES: 
The resultant excessive excretion of cystine which is least soluble of the 
naturally occurring amino acids leads to formation of crystals and eventually cystine 
calculi. 
3.4.7 CLINICAL SYMPTOMS:        
• Sudden renal colic or ureteric colic. 
• Radiating pain towards the groin and testicular region. 
• Intermittent biliary or intestinal colic. 
• Dysuria. 
• Oliguria. 
• Haematuria 
• Urinary retention. 
• Rigors and fever. 
• Nausea and vomiting. 
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3.4.8 DIAGNOSIS: 
 The diagnosis of kidney stones on the basis of, information obtained from 
history and physical examination. 
Other tests: 
 Complete blood count (CBC), looking for neutrophilia, (increased neutrophil 
granulocyte count) suggestive of bacterial infection, as seen in setting of 
struvite stones. 
 Blood tests for calcium, phosphorus, uric acid, and electrolytes. 
 Blood urea nitrogen (BUN) and creatinine to assess kidney functioning. 
 Urine analysis- microscopic examination of the urine, which show 
 Red blood cells. 
 Epithelial cells. 
 Urinary casts and crystals. 
 Pus cells. 
 Abdomen x-rays. 
 Ultra sound examination of the kidney. 
 Intra venous pyelogram. 
 Retrograde pyelogram. 
 MRI of the abdomen and kidneys. 
 Abdomen CT scan. 
 Stone analysis is done of collected stones can establish their composition, 
which in turn can help future preventive and therapeutic management. 
3.4.9 DIFFERENTIAL DIAGNOSIS: 
 Appendicitis. 
 Cholecystitis and cholelithiasis. 
 Ectopic pregnancy  
  Pelvic inflammatory disease. 
 Pancreatitis. 
 Gastric and duodenal ulcers. 
 Pyelonephritis. 
 Diverticulitis. 
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3.4.10. COMPLICATIONS: 
 Abscess. 
  Urinary fistula formation. 
 Ureteral scarring and stenosis.  
 Hydronephrosis. 
 Acute or Chronic Renal Failure. 
3.4.11 DIET FOR URINARY STONES:  
CALCIUM STONES: 
 A diet that increases blood and urine levels of calcium, such as caffeine and 
sodium. 
 Coffee, chocolate, cool drinks must be avoided. 
 Vitamin B6 is to reduce the urinary calcium levels. 
 Oxalate rich foods like spinach, beet, black tea, and nute are also avoided. 
 Also avoid vitamin C rich foods, because it converts to oxalate, oxalate 
excreted in urine. 
STRUVITE  STONES: 
 They modify their diet to increase the acidity of urine to inhibit bacterial 
growth. Urine acidifiers include specific tablets, animal proteins, and citrus 
fruits. 
URIC ACID STONES: 
 Avoid animal sources of protein. 
 Even vegetable sources of protein like pulses and grains are also restricted. 
CYSTINE STONES: 
 Avoid fish and grains containing protein. 
 The food which help to raise the PH of the urine such as vegetable juices and 
fruits can be take  
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CHAPTER-IV 
MATERIALS AND METHODS 
4.1 STUDY DESIGNS AND CONDUCT OF THE STUDY: 
 A Prospective open labelled phase-II non- randomized clinical trial on 
“KALLADAIPPU” was carried out in the Post Graduate Department Of Pothu 
Maruthuvam from the study period of AUGUST 2018- JUNE2019 at Government 
Siddha Medical College and Hospital, Palayamkottai-6270O2. Tirunelveli, 
Tamilnadu. The study was approved by Institutional Ethics Committee (IEC) (IEC, 
GSMC/IV-IEC/2017-Br-I-02/29.05.2017) 
 The study was registered in Clinical Trials Registry-India (CTRI) and the 
reference number is CTRI/ 2018/03//012710- MARCH 21 The study was approved by 
Institutional Animal Ethics Committee (IAEC), K.M College of Pharmacy, Madurai held 
on 01.05.2018. CPCSEA approval number: IAEC /P.BERNATH/ TNMGRMU/ MD(S) 
/321611002 / KMCP /24/ 2018 
4.2 SAMPLE DESIGN: 
 Totally 40 patients were selected in Kalladaippu Noi, among 40 (20-
Outpatients and 20-Inpatients) of both sexes between age groups of 20-60 years, were 
recruited for study and treated with the trial drug till the end of the study period.  
4.3 CRITERIA FOR THE SELECTION OF PATIENTS: 
 For the present study, patients were selected based on the following criteria 
 Ultra sonogram report, indicating the presence of renal calculus. 
 Urine analysis report, indicating the presence of crystals, albumin and RBCS 
deposition in the urine.  
 Clinical history of patients with the following symptoms                                                                     
Renal colicky pain, Burning micturition, Oliguria, Haematuria, Nausea and 
Vomiting. 
4.4. EXCLUSION CRITERIA 
• Age below 20  years and above 60 years 
• Chronic Appendicitis 
• Cholecystitis 
• Pyelonephritis 
• Recurrent UTI 
• Diabetes mellitus. 
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• Metabolic disorders like Hyperthyroidism, Hyperparathyroidism 
• Pelvic inflammatory disease 
• Chronic Renal Failure 
4.5. WITHDRAWAL CRITERIA 
• Intolerance to the drug and development of adverse reactions during drug 
trial. 
• Poor patient compliance & defaulters. 
• Patient turned unwilling to continue in the course of clinical trial. 
• Occurrence of any serious illness 
• Any other severe acute illness 
• Hypersensitivity of drugs to the patients 
TERMINATION CRITERIA 
• Not reporting subsequently 
• Voluntary termination 
                   STANDARD PREPARATORY PROCEDURE OF NVK                                                                                     
SOURCE OF TRIAL MEDICINES 
            The raw drugs required for the preparation of NERUNJI VER KUDINEER 
are collected by me from my garden and the raw drugs are authenticated by 
Medicinal botanist of Govt. Siddha Medical College, Palayamkottai. Then, the drugs 
are purified and medicines are prepared in the Gunapadam Practical hall, Govt. 
Siddha Medical College, Palayamkottai. 
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NERUNJI VER KUDINEER 
A)INGREDIENTS 
Drug Botanical 
name&family 
Quantity Important 
phytochemicals 
Action 
Nerunji ver Tribulus 
terrestris.L 
Zygophyllaceae 
5gm Dioscin 
 Protodioscin 
Diosgenin 
Diuretic Refrigerant 
Astringent           
Sirupeelai ver Aerva lanata.L 
Amaranthaceae 
5gm Apigetrin 
 Rutin  
Myricetin 
Diuretic Lithotriptic 
Sirukeerai ver Amaranthus 
tricolor.L 
Amaranthaceae 
5gm Amaranthin 
Isoamaranthin 
Diuretic 
 Seeragam Cuminum 
cyminum.L 
Apiaceae 
5gm Carvacrol  
Carvone  
Pinene 
Carminative 
Water  400 ml   
 
B) PURIFICATION OF DRUG 
Nerunji ver 
                    Cleaned and make it dried in shade 
Sirupeelai ver 
                    Cleaned and make it dried in shade 
Sirukeerai ver 
                     Cleaned and make it dried in shade  
Seeragam 
                     Cleaned and make it dried in shade                    
C) PROCESS OF PREPARATION  
              The purified drug 5 gm of Nerunji ver, 5 gm of sirupeelai ver 5 gm of 
sirukeerai ver and 5 gm of seeragam are dried and powdered, then it is added with 
400 ml of water and boiled until it is reduced to one fourth of its level and made 
kashayam to dispense for patients. 
  Dosage      :   100 ml twice a day. 
  Duration   : 30 days  
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           Dispensing 
 For the out-patients, the trial drug was given in 40 gm packets for      two days, 
they are instructed separately for preparing the decoction 
                 For the in-patients, the trial drug dispensed directly by me. 
4.6. TREATMENT 
NERUNJI VER KUDINEER (INTERNAL MEDICINE) 
 Reference : AATHMARATCHAMIRTHAM ENNUM  
                VAIDHYA SARASANGIRAGAM, Pg. No. 349,  
                            Gandhasamy Mudhaliyar 
Dosage                 : 100 ml BID - Morning and Evening.  
Duration    : 30 days. 
  
4.7. COLLECTION AND MAINTENANCE OF PATIENT’S DATABASE: 
 A proforma was prepared to collect details about the patient’s personal and 
family history, present symptoms, history of recent and past illness, laboratory 
investigations (including urine and blood analysis). Ultra sonogram, method adopted 
for the purpose of treatment and management of the disease and follow-up 
procedures. The details collected were recorded in proforma for each individual 
patient and database was maintained for all the patients. 
4.8. SELECTION OF TRIAL MEDICINE: 
 The trial medicine, NERUNJI VER KUDINEER (Internal) is selected based on 
their medicinal values in treating KALLADAIPPU NOI, mentioned in the Siddha 
literature AATHMARATCHAMIRTHAM ENNUM VAIDHYA SARASANGIRAGAM 
Page.no. 349. 
 The ingredient was collected, purified properly and prepared according to the 
literature. The drug is given to the patients for the entire course of treatment. 
References are enclosed in ANNEXURE-I 
 4.8.1 Pre Clinical Analysis of Trial Medicine:  
All the pre clinical studies of my trial drug had included Bio chemical 
analysis, acute toxicity studies and Pharmacological studies has done and cross 
checked before beginning the trial. 
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A) Biochemical Analysis: 
 Biochemical analysis of the trial medicine was performed at the Biochemistry 
unit of Government Siddha Medical College and Hospital, Palayamkottai. 
Experiments were conducted by the unit by following the standard procedures to 
known the presence of minerals. The results of the Biochemical Analysis and 
Inferences are given in results and observation. 
B) Phytochemical Analysis: 
 It was performed at the K.M.COLLEGE OF PHARMACY, MADURAI. 
Experiments were conducted by the unit by following standard procedures to known 
the presence of minerals and microbiology. The results of the phytochemical analysis 
and results are given in results and observation. 
C) Pharmacological Analysis:  
 Pharmacological actions of the trial medicine were studied at K.M College of 
Pharmacy, Madurai. Experiments were conducted with albino rats by following the 
standard procedures to determine the Pharmacological actions like Lithotriptic, 
Analgesic and diuretic effect. The results and inferences are given in results and 
observation. 
D) Toxicity studies: 
 The toxicity study for my trial drug was done by K.M COLLEGE OF 
PHARMACY, MADURAI. The results and interferences are given in results and 
observation. 
4.8.2 .Assessment: 
A.Clinical assessment: 
 The patients were subjected to the following investigations to establish the 
diagnosis. The investigations were carried out regularly before and after the treatment. 
• Routine laboratory investigations such as blood examination was tested 
biochemically to known the present functional status of the body and also 
urine tests was tested to known any depositions and other pathological 
constituents. 
• All the patients were subjected to USG Abdomen before and after the 
treatment. The USG reports of few patients are enclosed in ANNEXURE-II. 
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b.Siddha assessment: 
 Poriyaal arithal 
 Pulanaal arithal 
 Vinaathal 
 Mukkuttra nilaigal 
 Udal kattukal 
 Envagai thervugal 
 Nilam, Kaalam, Thegi 
4.9. OUTCOME OF THE STUDY: 
                   The outcome of the study was measured by complete reduction of clinical 
symptoms and clearance /reduction in the size of renal calculus by conform USG-
Abdomen, using the following Urolithiasis symptoms score. The score of each case at 
the time of enrolment and at the end of treatment were compared and on its basis the 
patient was informed that he/she was symptoms free and cured. 
Urolithiasis Symptom Score: 
(Circle relevant number on each line) 
1. Pain/colic 0- No pain 1- Mild pain 2 -Moderate pain 
3- Severe 
Pain 
2. Haematuria 0 –No Haematuria 1- Microscopic 2- Persistent 3 –Gross 
3. Dysuria 0 -No dysuria 1- Mild dysuria 2- Moderate dysuria 3- Severe 
4. Stone 1- Single stone 2- MultipleStone 
5. Size of 
Stones 
0- Grade < 
03mm 
1-3 mm to < 4 
mm 
2-4 mm to < 
5 mm 
3-5 mm and 
Above 
6. Position of 
stone in 
Kidney 
0- No stone in 
Kidney 
1-Pelvic ureteric 
junction 
2- Pelvis of 
kidney 
3 Calyces of 
Kidney 
7. Position of 
stone in ureter 
0- No stone in 
Ureter 
1- Lower part of 
Ureter 
2- Middle of 
ureter 
3- Upper 
part of 
Ureter 
8. Position of 
stone in 
Bladder 
0 -No stone in 
Bladder 
1 -Base of 
Bladder 
2- Intramural 
ureter 
 
Total scoring – 22, 1-7 mild, 8-14 moderate, 15-22 severe. 
Symptoms score – (Some of 8 circled numbers) 
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Statistical analysis: 
The collected data’s are presented in the form of percentage and figures and 
analysed using the SPSS 20.0(IBM). Data were expressed as Mean and Standard 
deviation. The significance of the difference between the mean of the baseline and 
final examinations was tested using the Paired “t” test. A probability value of <0.05 
was considered to be statistically significant. 
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CHAPTER V 
OBSERVATION AND RESULTS 
5.1. PRECLINICAL STUDY OF NERUNJI VER KUDINEER: 
5.1.1. Biochemical analysis:    
Preparation of the extract 
5 gm of drug was weighted accurately and placed in a 250ml clean beaker 
then 50ml of distilled water is added and dissolved well. Then it is boiled well for 
about 10 minutes.  It is cooled and filtered in a 100ml volumetric flask and then it is 
made up to 100ml with distilled water.  This fluid was taken for analysis. 
QUALITATIVE ANALYSIS 
S. 
NO EXPERIMENT OBSERVATION INFERENCE 
1 
TEST FOR CALCIUM 
 
A White precipitate 
is formed 
presence of 
calcium 
2 ml of the above prepared extract is 
taken in a clean test tube. To this 
add 2 ml of 4% ammonium oxalate 
solution 
2 
TEST FOR SULPHATE 
A white precipitate 
is formed 
presence of 
sulphate 2 ml of the extract is added to 5% barium chloride solution 
3 
TEST FOR CHLORIDE 
No white precipitate 
is formed 
Absence of 
chloride The extract is added with silver 
nitrate solution 
4 
TEST FOR CARBONATE 
No brisk 
effervescence is 
formed 
Absence of 
carbonate The extract is treated with 
concentrated HCL 
5 
TEST FOR STARCH 
Blue color is 
formed 
Presence of 
starch 
The extract is added with weak 
iodine solution 
 
 
6 
 
TEST FOR FERRIC IRON 
No blue colour is 
formed 
Absence of 
ferric iron 
The extract is acidified with glacial 
acetic acid and add potassium 
ferrocyanide 
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From  above table no 5.1.1 Analysis was noted that the presence of caicium, 
sulphate, starch, ferrous ion and  unsaturated compounds. 
 
 
 
7 
 
TEST FOR FERROUS IRON 
 
Blood red colour is 
formed 
 
presence of 
ferrous iron 
The extract is treated with 
concentrated nitric acid and 
ammonium thiocyanate solution 
8 
TEST FOR PHOSPHATE 
No yellow 
precipitate is 
formed 
Absence of 
phosphate 
The extract is treated with 
ammonium molybdate and 
concentrated nitric acid 
9 
TEST FOR ALBUMIN 
No yellow 
precipitate is 
formed 
Absence of 
albumin The extract is treated with Esbatch’s 
reagent 
10 
TEST FOR TANNIC ACID 
No blue black 
precipitate is 
formed 
Absence of 
tannic acid The extract is treated with ferric 
chloride 
11 
TEST FOR UNSATURATION 
It gets decolourised 
presence of 
unsaturated 
compounds 
Potassium permanganate solution is 
added to the extract 
12 
TEST FOR REDUCING SUGAR 
No colour change 
occurs 
Absence of 
reducing sugar 
5 ml of benedict’s qualitative 
solution is taken in a test tube and 
allowed to boil for 2 minutes and 
add 8- 10 drops of the extract and 
again boil it for 2 minutes 
13 
TEST FOR AMINO ACID 
No violet colour is 
formed 
Absence of 
Amino acid 
One or two drops of the extract is 
placed on a filter paper and dried 
well. After drying 1% Ninhydrin is 
sprayed over the same and dried 
well 
14 
TEST FOR ZINC 
No white precipitate 
is formed Absence of zinc The extract is treated with potassium ferrocyanide 
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5.1.2.Phytochemical analysis: 
Table:5.1.2.Qualitative phytochemical analysis of  NERUNJI VER KUDINEER 
 OBSERVATION INFERENCE 
1.Alkaloids An orange red precipitate produced Presence of alkaloids 
2.Flavanoids No characteristic change Absence of flavonoids 
3.Phenols A blue or green colour was formed Presence of phenols  
4.Glycosides Yellow colour was formed Presence of glycosides 
5.Steroids A red colour was produced in the 
chloroform layer 
Presence of steroids 
 
6.Tannins No characteristic change Absence of tannins 
7.Saponins No characteristic changes Absence of saponins 
8.Terpenoids Red colour layer was formed Presence of terpenoids 
 
The above table no.5.1.2 The Qualitative Phytochemical analysis was resulted 
in the presence of Alkaloids, Phenols, Glycosides, Steroids, Tannins and 
Terpenoides.   
 
5.1.3. Anti –microbial analysis of Nerunji ver Kudineer       
Sample 
Code 
Bacteria  Strains Name 
Staphylococcus 
aureus (G+) 
Streptococcus 
mutans (G+) 
 
Bacillus 
subtilis (G+) 
Klebsilla 
pneumonia (G-) 
E – coli  
(G-) 
NVK 15 14 11 - 10 
PC 27            15 27 27 25 
NC - - - - - 
Keys    PC     -     Positive Control (Streptomycin) 
NC          -    Negative Control                             
  -              -    No Zone 
Mm     -    Millimetre  
G+      -   Gram Positive Organis        
G-      -   Gram Negative Organism                              
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Fig.1.Staphylococcus aureus                                           Fig.2.Streptococcus mutans 
 
 
 
 
 
 
 
 
Fig.3.Bacillus subtilis                                                    Fig.4.Klebsiella pneumoniae 
 
 
 
 
 
 
 
 
                                                           
  Fig.5.E.coli 
 
 
 
 
 
 
 
 
 
 
The above table no 5.1.3 showed NERUNJI VER KUDINEER  was sensitive 
to Staphylococcus aureus, Streptococcus mutans,Bacillus subtilis and E.coli. Not 
sensitised to Klebsiella pneumonia. 
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5.1.4. PHARMACOLOGICAL STUDIES: 
5.1.4.1. LITHOTRIPTIC ACTIVITY OF NVK 
Table:1 Effect on Urinary output in Urolithiasis induced rats 
Days GP1 GP2 GP3 GP4 GP5 
0 6.25±0.42 6.30±0.46 6.45±0.70 6.75±0.72 7.45±0.65 
14 6.80±0.68 5.90±0.42**a 7.50±0.88**b 8.20±1.35**b 10.42±1.64**b 
28 7.45±0.85 5.40±0.26**a 7.65±1.32**b 9.20±1.62**b 10.80±1.80**b 
 
Table:2 & 3 EFFECT ON URINARY BIOCHEMICAL PARAMETERS ON 
14TH DAY & 28TH DAY 
GP 
Protein 
(mg/dl) 
Magnesium 
(mg/dl) 
Calcium 
(mg/dl) 
Uric 
acid 
(mg/dl) 
Creatinine 
(mg/dl) 
Oxalate 
(mg/dl) 
Phosphate 
(mg/dl) 
GP1 
74.90± 
1.70 
3.92± 
0.48 
5.48± 
0.74 
8.80± 
0.75 
0.82± 
0.16 
18.75± 
1.52 
37.65± 
2.82 
GP2 
152.28± 
4.45**(a) 
1.34 ± 
0.24**(a) 
27.22± 
1.87**(a) 
17.58 ± 
1.45**(a) 
1.56 ± 
0.22**(a) 
31.70 ± 
3.32**(a) 
78.63 ± 
4.36**(a) 
GP3 
88.35 ± 
3.90 
**(b)
 
2.62 ± 
0.30**(b) 
19.30 ± 
2.22**(b) 
11.68 ± 
0.88**(b) 
0.98 ± 
0.17**(b) 
25.25 ± 
2.65**(b) 
46.60 ± 
3.82**(b) 
GP4 
86.45 ± 
3.72**(b) 
2.35 ± 
0.48**(b) 
12.36 ± 
0.76**(b) 
11.25 ± 
0.56**(b) 
0.94 ± 
0.16**(b) 
23.75 ± 
2.48**(b) 
42.35 ± 
3.24**(b) 
GP5 
80.35± 
2.75**(b) 
3.28 ± 
0.60**(b) 
16.55 ± 
0.38**(b) 
7.65 ± 
0.75**(b) 
0.82 ± 
0.17**(b) 
21.30 ± 
1.70**(b) 
36.25 ± 
2.48**(b) 
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Table.4 EFFECT ON SERUM PARAMETERS ON 28TH DAY 
GP 
Magnesium 
(mg/dl) 
Calcium 
(mg/dl5) 
Uric acid 
(mg/dl) 
Creatinine 
(mg/dl) 
Oxalate 
(mg/dl) 
Phosphate 
(mg/dl) 
GP1 
4.92 
±0.54 
10.65 
±1.54 
3.36 
±0.26 
0.52 
±0.29 
6.42 
±0.72 
13.82 
±1.42 
GP2 
1.64 
±0.42**(a) 
17.52 
±2.45**(a) 
9.74 
±1.32**(a) 
1.24 
±0.59**(a) 
13.58 
±1.72**(a) 
29.28 
±3.55**(a) 
GP3 
3.78 
±0.55**(b) 
11.82 
±1.64**(b) 
4.28 
±0.82**(b) 
0.82 
±0.54**(b) 
9.56 
±0.96**(b) 
24.26 
±2.78**(b) 
GP4 
3.89 
±0.27**(b) 
11.76 
±1.52*(b) 
4.22 
±0.44**(b) 
0.79 
±0.51**(b) 
8.78 
±0.85**(b) 
22.72 
±2.69**(b) 
GP5 
6.74 
±0.36**(b) 
16.36 
±1.38**(b) 
6.21 
±0.48**(b) 
0.55 
±0.39**(b) 
12.35 
±0.31**(b) 
19.60 
±1.58**(b) 
 
GP1- Normal;   GP2- Lithiatic Control;   GP3-  NVK 
(100mg/kg);GP4- NVK (200mg/kg); GP5-Cystone herbal tablets (100mg/kg) 
 
 
GP 
Protein 
(mg/dl) 
Magnesium 
(mg/dl) 
Calcium 
(mg/dl) 
Uric 
acid 
(mg/dl) 
Creatinine 
(mg/dl) 
Oxalate 
(mg/dl) 
Phosphate 
(mg/dl) 
GP1 
76.87 
±3.82 
4.40 
±0.45 
7.28 
±0.63 
3.47 
±0.73 
0.95 
±0.32 
18.60 
±1.43 
33.22 
±3.45 
GP2 
165.28 
±7.25**(a) 
1.82 
±0.60**(a) 
22.75 
±1.62**(a) 
12.45 
±1.32**(a) 
1.68 
±0.60**(a) 
51.38 
±4.44**(a) 
81.48 
±4.82**(a) 
GP3 
91.28 
±5.64**(b) 
2.50 
±0.43**(b) 
13.65 
±1.12**(b) 
8.58 
±0.47**(b) 
1.28 
±0.76**(b) 
26.81 
±2.61**(b) 
45.73 
±3.42**(b) 
GP4 
88.74 
±5.65**(b) 
3.94 
±0.58**(b) 
11.65 
±0.94**(b) 
8.25 
±0.42**(b) 
1.27 
±0.46**(b) 
24.33 
±2.47**(b) 
44.46 
±3.23**(b) 
GP5 
84.70 
±4.88**(b) 
3.55 
±0.46*(b) 
11.28 
±0.48**(b) 
7.30± 
0.34**(b) 
1.24 
±0.40**(b) 
21.32 
±2.18**(b) 
41.65 
±2.30**(b) 
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• Values are expressed as mean ± SEM 
• Values were found out by using ONE WAY ANOVA Followed by Newman 
keul’s multiple range tests. 
• **(a) Values were significantly different from normal control (GP1) at P< 0.01 
• **(b) Values were significantly different from Lithiatic control (GP2) at P<0.01    
            The above table no.4  showed the siddha poly herbal formulation NERUNJI 
VER KUDINEER had significant (p<0.01) LITHOTRIPTIC activity as compare to 
normal control animals. 
5.1.4.2. DIURETIC ACTIVITY OF  NERUNJI VER KUDINEER 
                             Table:1 Diuretic activity of NERUNJI VER KUDINEER  
Group Treatment 
 
Urine Volume 
       I Normal saline 10ml/kg 8.15±0.50 
       II Frusemide 20mg/kg 12.85±0.90** 
      III Nerunjiver Kudineer100mg/kg 11.15±0.65** 
      IV Nerunjiver Kudineer200mg/kg 12.40±0.90** 
 
                        Table 2: Natriuretic activity of NERUNJI VER KUDINEER 
Treatment Na+ K+ Na+/K+ 
Normal saline 10ml/kg 1.75±0.12 0.75±0.04 2.33 
Frusemide 20mg/kg 3.28±0.26** 0.90±0.07** 3.64 
Nerunjiver 
Kudineer100mg/kg 
1.96±0.17* 0.71±0.01ns 2.76 
Nerunjiver 
Kudineer200mg/kg 
2.28±0.20** 0.69±0.02ns 3.30 
 
Values are Mean ± SEM, n=6, *p<0.05, **p<0.01, NS - not significant 
Conclusion 
                  From the above table no 1 & 2, it is concluded that Nerunji Ver Kudineer 
used by Siddha preparation traditionally showed significant diuretic activity. The 
experimental evidence obtained in the laboratory model could provide a rationale for 
the traditional use of this siddha preparation as diuretic. 
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5.1.4.3 Evaluation of Analgesic Activity of Nerunji Ver Kudineer in Animal 
Models 
Table 1. Effects of siddha formulation Nerunji Ver Kudineer on acetic acid–induced 
writhing response (N=6 in each group). 
Groups Treatment (number of writhing 
movements) (Mean ± S.E) 
Percentage % 
Group I Distilled water 34.15 ± 2.78   
Group II Diclofenac sodium 
10mg/kg 
  6.38 ± 0.74*b 
 
81.31% 
Group III 100mg/kg Nerunji ver 
Kudineer 
14.08 ± 1.68*b 58.77% 
Group IV 200mg/kg Nerunji Ver  
Kudineer 
13.15 ± 1.34*b 61.49% 
 
• Values are expressed as mean ± SEM. 
        * (b) Values are significantly different from Toxic  control G2 at  P<0.01 
CONCLUSION: 
It can be concluded that possesses anti-nociceptive properties which are 
probably mediated via inhibition of prostaglandin synthesis as well as central 
inhibitory mechanisms which may be of potential benefit for the management of pain 
and inflammatory disorders. 
5.1.5. TOXICITY STUDY OF NERUNJI VER KUDINEER 
TABLE. 1. ACUTE TOXICITY STUDY OF NERUNJI VER KUDINEER 
 Dose (mg.kg-1) Sign of Toxicity 
(ST.NB-1) 
Mortality (D.S-1) 
Group I              0                      0/3            0/3 
Group II            300                      0/3            0/3 
Group III           2000                      0/3            0/3 
 
 The acute toxicity of Nerunji ver kudineer on experimental mice was tested 
using OECD-423 guidelines, where ST- sign of toxicity; NB- normal behaviour; D- 
died; S- survive.  Values are expressed as number of animals (n=3). 
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B.Effect of  NERUNJI VER KUDINEER in subchronic toxicity        
Table.2. Effect of Nerunji ver kudineer on body weight changes in rats: 
Treatment Day 1 Day 5 Day 10 Day 20 
Control 185.25±6.11 187.47  ±6.25 196.15 ±6.40 196.7±6.60 
Nerunji ver kudineer 
 50 mg.kg-1 
194.35 ±6.4 193.35 ±6.35 198.25 ±6.70 198.30±6.75* 
Nerunji ver kudineer 
100 mg.kg-1 
186.40 ±5.7 189.35  ±6.45 196.55  ±7.10 197.36±6.33* 
Nerunji ver kudineer 
200 mg.kg-1 
195.35  ±7.2 198.20±6.55 198.90  ±7.20** 206.45±7.31** 
Nerunji ver kudineer 
400 mg.kg-1 
187.70  ±6.05 192.15 ±5.65 195.60  ±6.35** 207.66±7438** 
The effect of NVK was observed for their effect on the body weight changes 
from the study it was observed that, there was significant increase (p<0.05) in body 
weight in all the animals observed. 
C.Effect of Nerunji ver kudineer on kidney, heart, liver and brain in rats     
The effects of Nerunji ver kudineer on kidney, heart, liver and brain of the 
rats were observed.    From the study it was clear that, significant (p<0.01) changes 
in the weights of various organs of the animals occurred with higher doses of the 
extract (400 mg.kg-1 bwt), but macroscopic examinations did not show any changes 
in colour of the organs of the treated animals compared with the control.   The 
results are shown below table no.3 
Table no.3.Effect of NVK on kidney, liver, heart and brain in rats 
                    Treatment Heart 
(gms) 
Kidney 
(gms) 
Liver 
(gms) 
Brain 
(gms)   
Control 0.36 ± 
0.07 
0.66± 0.05 3.34± 0.07 0.67± 
0.75 
Nerunjiver kudineer@50 
mg.kg-1 
0.37± 0.04 0.82± 0.05 3.44± 0.05 0.70± 0.5 
Nerunjiver kudineer@100 
mg.kg-1 
0.38± 0.08 0.80± 0.06 3.36±0.04 0.68± 0.4 
Nerunjiver kudineer@ 200 
mg.kg-1 
0.37± 0.06 0.75± 0.04 3.34± 0.04 0.75± 
0.07 
Nerunjiver kudineer@400 
mg.kg-1 
0.36± 0.05 0.76± 0.05 3.37± 0.05 0.77± 
0.07 
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D.Effect of NVK on biochemical profiles of rats   
 The effect of  NVK on various biochemical parameters of the experimental 
animal ‘rats’ were tested.  From the study it was evident that, there was significant 
decrease (p<0.05) in the plasma glucose level in treated rats especially at higher dose 
(400 mg.kg-1) compared with control rats.   The control rats were administered only 
with 5 ml of normal saline.   Significant decrease (p<0.05) in the plasma total 
cholesterol (TC), triglyceride (TG) and LDL-cholesterol levels were observed.   But a 
significant increase (p<0.05) in HDL-cholesterol levels were observed in all the 
treated animals compared with the control animals. AST, ALT and ALP levels were 
also normal in the NVK treated animals. From the results of biochemical study there 
was no evidence of severe toxicity associated with the administration of higher 
concentration of NVK.   The results are shown in Table no.4. 
Table no.4.Effect of NVK on biochemical profiles of rats 
Treatment 
AST 
(IU.l-1) 
ALT 
(IU.l-1) 
ALP 
(IU.l-1) 
TP 
(g.l-1) 
ALBUMIN 
(g.l-1) 
Control 328.5±12.40 
71.5± 
3.18 
253.58± 
8.80 
69.85± 
3.32 
39.15±2.35 
Nerunji ver 
kudineer@50 mg.kg-1 
317.0±9.50** 
69.5± 
2.20** 
266.10± 
2.75** 
70.30± 
2.32 
36.30±2.65 
Nerunji ver kudineer@ 
100 mg.kg-1 
318.3±7.20** 
67.1± 
3.15** 
260.18± 
6.70** 
80.15± 
2.82 
38.30±3.05 
Nerunji ver kudineer@ 
200 mg.kg-1 
313.4±7.95 
64.4± 
2.90 
265.00± 
5.20 
69.25± 
3.32 
40.20±2.75 
Nerunji ver kudineer@ 
400 mg.kg-1 
323.2± 8.20 
64.3± 
3.52 
269.40± 
4.40 
74.05± 
2.58  
39.48±2.70 
E.Effect of Nerunji ver kudineer on haematological parameters in rats   
The effects of Nerunji ver kudineer were observed for its effect on 
haematological parameters on the experimental rats. From the study it was evident 
that, a significant increase (p<0.01) were observed in the haemoglobin contents and  
RBC count  in the group treated with 200 mg.kg-1 body weight of Nerunji ver 
kudineer and a significant decrease of the parameters occurred in the group treated 
with 400 mg.kg-1 b.w.t compared with the control.   There was no significant change 
in the calcium level in all the treated animals compared to the control. 
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Table no.5. Effect of NVK on haematological parameters in rats 
 
Treatment 
Haemoglobin 
(mg.dl-1) 
RBC 
(106 /mm3) 
WBC 
(106 /mm3) 
Calcium 
(mg.dl-1) 
Control 13.35± 0.27 9.15± 0.02 11.45± 0.05  9.45 ±0.02 
Nerunji ver kudineer@ 50 
mg.kg-1 
14.55± 0.28* 9.50± 0.04*   9.55± 0.01*  9.33 ±0.02 
Nerunji ver kudineer@ 100 
mg.kg-1 
14.35± 07* 9.55± 0.02*   8.35± 0.32*  9.21±0.20 
Nerunji ver kudineer@ 200 
mg.kg-1 
12.75± 0.22* 8.33± 0.12* 11.45± 0.03*  9.51 ±0.13 
Nerunji ver kudineer@ 400 
mg.kg-1 
13.5± 0.35* 8.46± 0.45*   10.5± 0.13*  9.73 ±0.02 
 
The overall results suggest that Nerunji ver kudineer are non toxic to the 
haaematopoietic and leucopoietic system.   The haematopoietic and leucopoietic 
systems are the most sensitive targets for toxic compounds and an important index of 
physiological and pathological status in man and animal (Adeneye, et al., 2006).(13)   
Therefore, it is possible to assume that the Nerunji ver kudineer is non haematotoxic. 
Discussion 
The acute toxicity study of Nerunji ver kudineer was carried out as per OECD-
423 guidelines, no mortality was observed in both the animals of control group as 
well as animals treated with a maximum dose of 2000 mg.kg-1.   Hence, in subchronic 
toxicity started from 200 mg.kg-1 of dose as per 1/10th of 2000 mg.kg-1 of acute dose 
i.e. hasn’t shown any abserved mortality during the period of study. There was no 
significant change in animal behaviour due to the absence of toxicity.  Hence, this can 
be concluded that, the Nerunji   ver Kudineer has been taken as per the standard 
dosing protocol for the beneficial effect for suitable clinical conditions. 
5. 2 .CLINICAL STUDY 
The results obtained from the presence study were recorded in the proforma 
with respect to the following parameters for each patient both out-patients and in-
patients. They were analysed statistically in order to arrive at the percentage 
composition. 
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1. Age (Kaalam) Distribution 
2. Gender Distribution 
3. Occupational Status 
4. Dietary Habits 
5. Marital Status 
6. Personal Habits 
7. Paruvakaalam (Season) 
8. Thinai (Land) 
9. Thegathathuvam (Thegi) 
10. Manothathuvam (Gunam) 
11. Uyir Thathukal 
a) Derangement of Vatham 
b) Derangement of Pitham 
c) Derangement of Kabam 
12. Udal Thathukal 
13. Kosangal 
14. 14 Vegangal 
15. Envagai Thervugal 
16. Neerkuri 
17. Neikuri 
18. Duration of Illness 
19. Number of Stones 
20. Position of Stones 
21. Size of Stones 
22. Urolithiasis Symptoms Score 
23. Grading outcomes of the study 
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Table 1 : AGE DISTRIBUTION 
sl 
no 
Age 
Out patients In patients 
No. of 
Cases 
Percentage 
No. of 
Cases 
Percentage 
1 
Vatha kaalam  
(0-33 years) 
6 30% 1 5% 
2 
Pitha kaalam  
(34-66 years) 
14 70% 19 95% 
3 
Kabha kaalam 
(67-100 years) 
0 0% 0 0% 
 
Figure 1 : AGE DISTRIBUTION 
 
 
 
 
 
 
 
 
 
 
 
Inference: 
             The above table reveals that majority of both out patients 70% and in patients 
95% comes under Pitha kaalam, 30% of outpatients and 5% of inpatients comes under 
Vatha kaalam.  
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                            Table 2 : GENDER DISTRIBUTION 
  
  
      
S.no Gender 
Out patients In patients 
No. of 
Cases 
Percentage 
No. of 
Cases 
Percentage 
1 Male 16 80% 3 15% 
2 Female 4 20% 17 85% 
 
Figure 2 : GENDER DITRIBUTION 
 
 
Inference: 
From the above table, out patients  Male 80% and Female 20%  were affected. 
And inpatients 15% were Male and 85% were Female affected. 
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                           Table 3 : OCCUPATIONAL STATUS 
            
sl 
no 
Occupation 
Out patients In patients 
No. of 
Cases 
Percentage 
No. of 
Cases 
Percentage 
1 House Wife 4 20% 12 60% 
2 
Standing work 
style 
8 40% 6 30% 
3 
Sedentary work 
style 
3 15% 0 0% 
4 Student 1 5% 0 0% 
5 Retired person 0 0% 1 5% 
6 Driver 2 10% 1 5% 
7 Farmer 2 10% 0 0% 
                                     
Figure 3 : OCCUPATIONAL STATUS 
 
Inference:  
Among out patients majority of them are standing workers 40%, compared to 
otheir Works. Among in patients majority of them are house wives 60%, compared to 
other Works. 
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                                   Table 4 : DIETARY HABITS 
            
sl no Diet 
Out patients In patients 
No. of 
Cases 
Percentage 
No. of 
Cases 
Percentage 
1 Vegetarian 2 10% 4 20% 
2 
Vegetarian & 
Non 
Vegetarian 
18 90% 16 80% 
 
Figure 4 : DIETARY HABITS 
 
 
Inference: 
                  This table reveals that majority of out patients 90% and in patients 80%, 
were both Vegetarian and Non- Vegetarian, compared to pure Vegetarian. 
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Table 5 : MARITAL STATUS 
            
sl no Marital 
Out patients In patients 
No. of 
Cases 
Percentage 
No. of 
Cases 
Percentage 
1 Married 16 80% 19 95% 
2 Unmarried 4 20% 1 05% 
 
Figure 5 : MARITAL STATUS 
 
 
Inference: 
         This table reveals that majority of cases in out patients 80% and in patients 95% 
were Married, compared to Unmarried. 
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Table 6 : PERSONAL HABITS 
            
sl no Habits 
Out patients In patients 
No. of 
Cases 
Percentage 
No. of 
Cases 
Percentage 
1 Alcohol 1 5% 1 5% 
2 Smoking 2 10% 0 0% 
3 
Alcohol with 
smoking 
5 25% 1 5% 
4 
Tobacco / 
Betel chewing 
0 0% 0 0% 
5 
No Bad 
Habits 
12 60% 18 90% 
 
Figure 6 : PERSONAL HABITS 
 
Inference: 
                   This table reveals that majority of them out patients 60% and in patients 
90% does not have Bad Habits, compared to other Bad Habits.  
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Table 7 : PARUVAKAALAM (SEASON) 
      
sl 
no 
Paruvakaalam 
Out patients In patients 
No. of 
Cases 
Percentage 
No. of 
Cases 
Percentage 
1 Kaarkaalam 2 10% 2 10% 
2 Koothirkaalam 2 10% 1 5% 
3 Munpanikaalam 1 5% 1 5% 
4 Pinpanikaalam 2 10% 4 20% 
5 Ilavenil 8 40% 9 45% 
6 Mudhuvenil 5 25% 3 15% 
 
Figure 7 : PARUVAKAALAM (SEASON) 
 
Inference:  
Among out patients,majority of them  were Ilavenil Kaalam40% and 
mudhuvenil 25%. And  in patients, majority of them were Ilavenil Kaalam 45% and 
also Pinpani Kaalam 20%. 
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                                             Table 8 : THINAI (LAND) 
            
sl no Thinai 
Out patients In patients 
No. of 
Cases 
Percentage 
No. of 
Cases 
Percentage 
1 Kurunji (Hill) 0 0% 0 0% 
2 Mullai (Forest) 0 0% 0 0% 
3 
Marutham 
(Fertile) 
15 75% 16 80% 
4 
Neithal 
(Coastal) 
5 25% 4 20% 
5 Paalai (Desert) 0 0% 0 0% 
 
Figure 8 : THINAI (LAND) 
 
Inference: 
                  Among out patients, 75% were Marutham, 25% were Neithal Among in 
patients, 80% were Marutham, 20% were Neithal. 
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Table 9 : THEGA THATHUVAM 
            
Sl 
no 
Thegi 
Out patients In patients 
No. of 
Cases 
Percentage 
No. of 
Cases 
Percentage 
1 Vatha 4 20% 5 25% 
2 Pitha 14 70% 12 60% 
3 Kabha 2 10% 3 15% 
 
Figure 9 : THEGA THATHUVAM 
 
 
Inference: 
               Among out patients, 20% were Vatha Thegi, 70% were Pitha Thegi, 10% 
were Kabha Thegi. Among in patients, 25% were Vatha Thegi, 60% were Pitha 
Thegi, 15% were Kabha Thegi. 
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Table 10 : MANO THATHUVAM (GUNAM) 
            
Sl 
no 
Gunam 
Out patients In patients 
No. of 
Cases 
Percentage 
No. of 
Cases 
Percentage 
1 Sathuvagunam 4 20% 3 15% 
2 Rajogunam 15 75% 14 70% 
3 Thamogunam 1 5% 3 15% 
 
Figure 10 : MANO THATHUVAM (GUNAM) 
 
Inference:  
           Among out patients, 75% were Rajogunam, 20% were Sathuvagunam,  5% 
were Thamogunam. 
           Among in patients, 70% were Rajogunam, 15% were Sathuvagunam, 15% 
were Thamogunam. 
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Table 11 : UYIR THATHUKAL 
A) Derangement of Vatham 
Sl 
no 
Vatham 
Out patients In patients 
No. of 
Cases 
Percentage 
No. of 
Cases 
Percentage 
1 Pranan 3 15% 2 10% 
2 Abanan 20 100% 20 100% 
3 Viyanan 20 100% 20 100% 
4 Uthanan 0 0% 0 0% 
5 Samanan 20 100% 20 100% 
6 Nagan 0 0% 6 30% 
7 Koorman 0 0% 4 20% 
8 Kirugaran 0 0% 0 0% 
9 Thevathathan 0 0% 0 0% 
10 Thanajeyan - - - - 
 
Figure 11 A : Derangement of Vatham 
 
Inference: 
    This table reveals that all the out patients and in patients have Derangement in 
Abanan Viyanan and Samanan Vayus 100% were affected, compared to other Vayus. 
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Table 11 : UYIR THATHUKAL 
B) Derangement of Pitham 
            
Sl 
no 
Pitham 
Out patients In patients 
No. of 
Cases 
Percentage 
No. of 
Cases 
Percentage 
1 Analapitham 5 20% 6 30% 
2 Ranjagapitham 1 5% 3 15% 
3 Sathagapitham 16 80% 12 60% 
4 Prasagapitham 0 0% 0 0% 
5 Alosagapitham 0 0% 0 0% 
 
Figure 11 B : Derangement of Pitham 
 
 
Inference:  
             This table reveals that majority of the out patients 80% and in patients 60% 
were affected in Sathagapitham. And few cases affected Ranjagapitham and 
Analapitham. 
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Table 11 : UYIR THATHUKAL 
C) Derangement of Kabam 
            
Sl 
no 
Kabam 
Out patients In patients 
No. of 
Cases 
Percentage 
No. of 
Cases 
Percentage 
1 Avalambagam 0 0% 1 5% 
2 Kilethagam 5 25% 7 35% 
3 Pothagam 0 0% 0 0% 
4 Tharpagam 0 0% 0 0% 
5 Santhigam 6 3O% 3 15% 
 
Figure 11 C : Derangement of Kabam 
 
 
Inference: 
          This table reveals that majority of out patients  35% and in patients 25% was 
affected Kilethagam. And some patients were affected Avalambagam and santhigam. 
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Table 12 : UDAL THATHUKAL 
            
Sl 
no 
Udal Thathukal 
Out patients In patients 
No. of 
Cases 
Percentage 
No. of 
Cases 
Percentage 
1 Saaram 20 100% 16 80% 
2 Senneer 3 15% 4 20% 
3 Oon 0 0% 0 0% 
4 Kozhuppu 0 0% 0 0% 
5 Enbu 8 40% 10 50% 
6 Moolai 0 0% 0 0% 
7 
Sukkilam / 
Suronitham 
0 0% 0 0% 
 
Figure 12 : UDAL THATHUKAL 
 
Inference: 
      The table no.12 reveals that majority of the out patients 100% and in patients 80% 
were affected by Saaram. And few cases were also affected by  Enbu and Senneer. 
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Table 13 : KOSANGAL 
            
Sl 
no 
Kosangal 
Out patients In patients 
No. of 
Cases 
Percentage 
No. of 
Cases 
Percentage 
1 Annamayakosam 17 85% 16 80% 
2 Pranamayakosam 3 15% 4 20% 
3 Manomayakosam 0 0% 0 0% 
4 Vignamayakosam 0 0% 0 0% 
5 Anandamayakosam 0 0% 0 0% 
 
Figure 13 : KOSANGAL 
 
 
Inference: 
       This table reveals that majority of the out patients 85% and in patients 80% were 
affected by Annamayakosam. And few cases were affected by Pranamayakosam. 
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Table 14 : 14 VEGANGAL 
            
Sl 
no 
Vegangal 
Out patients In patients 
No. of 
Cases 
Percentage 
No. of 
Cases 
Percentage 
1 Nithirai 6 30% 7 35% 
2 Siruneer 20 100% 20 100% 
                  
Figure 14 : 14 VEGANGAL 
 
 
Inference: 
             This table reveals that majority of the out patients 100%  and in patients  
100% were affected by Siruneer. Few cases were affected by nithirai. And other 
vegangal were not affected. 
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Table 15 : ENVAGAI THERVUGAL 
Sl 
no 
Envagai 
Thervugal 
Out patients In patients 
No. of 
Cases 
Percentage 
No. of 
Cases 
Percentage 
1 Naa 0 0% 0 0% 
2 Niram 0 0% 0 0% 
3 Mozhi 0 0% 0 0% 
4 Vizhi 3 15% 5 25% 
5 Malam 0 0% 0 0% 
6 Moothiram 20 100% 20 100% 
7 Sparism 5 25% 07 35% 
8 Naadi 
    
  a) Vathapitham 7 35% 5 25% 
  b) Vathakabam 1 5% 4 20% 
  c) Pithavatham 12 60% 11 55% 
  d) Pithakabam 0 0% 0 0% 
  e) Kathavatham 0 0% 0 0% 
  f) Kabhapitham 0 0% 0 0% 
Figure15: ENVAGAI THERVUGAL 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
0% 0% 0%
15%
0%
100%
25%
35%
5%
60%
0% 0% 0%
25%
100%
35%
25%
20%
55%
Series3
Series2
Series1
 
Inference: This table understood that majority of the out patients 100% and in patients 
100% that  Moothiram was  affected. And majority of cases Pithavatha  naadi was 
mostly observed. 
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Table 16 : NEERKURI 
Sl no Type of Test Result 
Out patients In patients 
No. of 
Cases 
Percentage 
No. of 
Cases 
Percentage 
1 Niram (Color) 
Normal 2 10% 5 25% 
Yellowish 14 60% 14 70% 
Yellowish 
Red 
4 20% 1 5% 
2 
Edai (Specific 
Gravity) 
Normal 0 0% 0 0% 
Affected 20 100% 20 100% 
3 
Manam 
(Smell) 
Normal 0 0% 0 0% 
Affected 0 0% 0 0% 
4 Nurai (Froth) 
Normal 0 0% 0 0% 
Affected 0 0% 0 0% 
5 
Enjal 
(Deposits) 
Absent 0 0% 0 0% 
Present 16 80% 17 85% 
 
Figure 16 : NEERKURI 
 
Inference: 
               Majority of patients have Yellowish Urine. All patients 100%  were affected 
by Edai  i.e Specific gravity. Enjal are also present in many patients. 
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Table 17 : NEIKURI 
Sl 
no 
Neikuri 
Out patients In patients 
No. of 
Cases 
Percentage 
No. of 
Cases 
Percentage 
1 Vathaneer 4 20% 3 15% 
2 Pithaneer 13 65% 15 75% 
3 Kaphaneer 3 15% 2 10% 
 
Figure 17 : NEIKURI 
 
Inference: 
             Majority of the patients, have  Pitha Neer (65% out patients and 75% in 
patients), and then Vatha Neer (20% out patients and 15% in patients), and also in few 
patients  Kabha neer  found. 
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                               Table 18 : DURATION OF ILLNESS 
Sl no Duration 
Out patients In patients 
No. of Cases Percentage No. of Cases Percentage 
1 Less than 8 weeks 17 85% 18 90% 
2 2 - 6 months 2 10% 2 10% 
3 6 - 12 months 1 5% 0 0% 
4 1 - 1 1/2 years 0 0% 0 0% 
 
Figure 18 : DURATION OF ILLNESS 
 
 
Inference: 
           During  the time of period less than 8 weeks and  have majority of out patients. 
During the time of period  less than 8 weeks have majority of in patients.And 2-6 
months have few patients. 
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Table 19 : NUMBER OF STONES 
Sl 
no 
No. of 
Stones 
Before Treatment After Treatment 
Out patients In patients Out patients In patients 
No of 
Cases 
Percen
tage 
No of 
Cases 
Percen
tage 
No of 
Cases 
Percen
tage 
No of 
Cases 
Percen
tage 
1 Single 10 50% 11 55% 3 15% 4 20% 
2 Multiple 10 50% 9 45% 2 10% 2 10% 
 
Figure 19 : NUMBER OF STONES 
 
 
Inference: 
              This table reveals,  before treatment majority of the(50% out and 50% in 
patients)  has Single stone, and few cases has Multiple stones. But after treatment 
(15% out and 20% in patients) were Single stone, and few were Multiple stones. 
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Table 20 : POSITION OF STONES IN URINARY SYSTEM 
Sl 
no 
Position of 
Stones 
Out patients In patients 
No. of 
Cases 
Percentage 
No. of 
Cases 
Percentage 
1 Both Kidneys 2 10% 2 10% 
2 Right Kidney 9 45% 10 50% 
3 Left Kidney 7 35% 8 40% 
4 Right Ureter 1 5% 0 0% 
5 Left Ureter 1 5% 0 0% 
 
Figure 20 : POSITION OF STONES IN URINARY SYSTEM 
 
Inference: 
               Majority of cases of out patients 50% has calculi in Right Kidney . And also 
in patients 35% has calculi in Left Kidney. 
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Table 21 : SIZE OF STONES 
sl 
no 
Size of 
Stones 
Before Treatment After Treatment 
Out patients In patients Out patients In patients 
No 
of 
Cas
es 
Percent
age 
No 
of 
Cas
es 
Percent
age 
No 
of 
Cas
es 
Percent
age 
No 
of 
Cas
es 
Percen
tage 
1 
 Above 
5mm  
12 60% 4 20% 4 20% 3 15% 
2 
4 - 5 
mm 
2 10% 8 40% 5 20% 5 25% 
3 
1 – 3 
mm 
6 30% 5 25% 7 35% 7 35% 
4 nil 0 0% 3 15%   4 20% 5 25% 
 
Fig 21 : SIZE OF STONES 
 
Inference  
   Before treatment,  the USG reports of majority of cases, stone size will be 
5mm and above , and  1-3mm  in second major cases. After treatment majority of the 
cases, stone size will be upto <3mm. Thus the drug will be reduce the stone size.  
P<0.0001 was considered statistically significant difference. 
82 
 
Table 22 : UROLITHIASIS SYMPTOMS SCORE 
Sl 
no 
Types of 
score 
Before After 
Out patients In patients 
Out 
patients 
In patients 
No 
of 
Cas
es 
Percent
age 
No 
of 
Cas
es 
Percent
age 
No 
of 
Cas
es 
Perc
enta
ge 
No 
of 
Ca
ses 
Perce
ntage 
1 
15 - 22 
(severe) 
5 25% 7 35% 0 0% 0 0% 
2 
8 - 14 
(moderate) 12 60% 13 65% 3 15% 1 5% 
3 1 - 7 (mild) 3 15% 0 0% 3 15% 4 20% 
4 No Symptoms 0 0% 0 0% 14 70% 15 75% 
 
Figure 22 : UROLITHIASIS SYMPTOMS SCORE 
 
Inference:           
The above table resembles that the score will be severe ( out patients 35% and 
in patients 35%). And moderate in (60% of out patients and 65% of in patients),. 
Hence the score will be gradually decreased during treatment. And finally after the 
study (70% of out patients and 75% of in patients) have no symptoms.  P<0.0001 was 
considered statistically significant difference. 
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Table 23 : GRADING OUTCOMES OF THE STUDY 
            
Sl 
no 
Types of 
Grading 
Out patients In patients 
No. of 
Cases 
Percentage 
No. of 
Cases 
Percentage 
1 Good 15 75% 10 50% 
2 Moderate 5 25% 9 45% 
3 Poor 0 0% 1 5% 
 
Figure 23 : GRADING OUTCOMES OF THE STUDY 
 
 
Inference: 
               From the above table that  majority of (out patients 75% and in patients 
50%)  have good response. Moderate response were observed in (25% of out patients 
and 45% of in patients). Thus the trial drug is very effective in curing kalladaippu noi. 
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Table 24 : Statistical Analaysis: 
Parameters Treatment Mean Standard 
Deviation 
“t” 
value  
P value 
Size of Stone 
(mm) 
BT 6.5375 5.45540  
    4.873 
 
< 0.0001 AT 2.7750 3.60190 
Urolithiasis 
Symptom 
Score 
BT 12.4000 4.17440  
     
3.065 
 
< 0.0001 
AT 1.7250 3.55894 
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CASE SHEET OF 20 OUT PATIENTS TREATED FOR  
KALLADAIPPU NOI 
 
S. 
No 
Op. 
No Name Age Sex 
Starting Of 
Treatment 
End of 
treatment 
No Of 
Days 
Treated 
Result 
1. 44662 Karthick 26 M 22/05/2018 21/06/2018 30 Days Fair 
2. 44701 Saraswathi 36 F 22/05/2018 21/06/2018 30 Days Fair 
3. 45298 Annamalai 33 M 24/05/2018 23/06/2018 30 Days Fair 
4. 47187 Lakshmi Arun 35 M 31/05/2018 29/06/2018 30 Days Good 
5. 50375 Ponraj 31 M 13/06/2018 11/07/2018 30 Days Fair 
6. 55421 Buharisherif 46 M 02/07/2018 31/07/2018 30 Days Good 
7. 55935 Shanthi 50 F 04/07/2018 03/08/2018 30 Days Good 
8. 56318 Venkatachalam 44 M 05/07/2018 04/08/2018 30 Days Fair 
9. 58900 Marimuthu 26 M 14/07/2018 13/08/2018 30 Days Fair 
10. 58928 Gunasekaran 60 M 14/07/2018 13/08/2018 30 Days Fair 
11. 78755 Sivakumar 37 M 22/09/2018 20/10/2018 30 Days Fair 
12. 77895 Rakesh 19 M 19/09/2018 17/10/2018 30 Days Good 
13. 104995 Subbaiah 36 M 23/11/2018 21/12/2018 30 Days Good 
14. 103629 Raja 25 M 14/12/2018 14/01/2019 30 Days Good 
15. 103830 Joseph 28 M 15/12/2018 13/01/2019 30 Days Fair 
16. 105355 Murugammal 38 F 20/12/2018 19/01/2019 30 Days Fair 
17. 105373 Pushpam 43 F 20/12/2018 19/01/2019 30 Days Good 
18. 17054 Samidurai 60 M 15/02/2019 15/03/2019 30 Days Fair 
19. 33003 Aazath 55 M 06/04/2019 05/05/2019 30 Days Fair 
20. 38353 Alex 37 M 25/04/2019 25/05/2019 30 Days Fair 
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                  BLOOD INVESTIGATION 
S. 
No
. 
OP 
No 
Before Treatment After Treatment 
WBC 
TC 
WBC-DC% 
ESR 
1 hr 
HB 
WBC 
TC 
 
WBC -DC% ES
R 
1 
hr 
HB 
P L E P L E  
1. 44662 8100 61 33 6 21 12 6400 62 34 4 18 13 
2. 44701 8000 63 30 7 12 13 6800 59 40 1 18 13 
3. 45298 8000 60 36 4 15 13.7 7000 64 33 3 18 13.8 
4. 47187 7200 61 35 4 15 12.4 8000 55 43 2 12 12.6 
5. 50375 7600 64 32 4 20 9.8 7400 62 34 4 18 10 
6. 55421 7500 64 27 4 16 10.5 7300 58 30 7 20 10 
7. 55935 6800 64 32 4 24 12.6 7200 63 30 7 20 11.8 
8. 56318 8000 60 36 4 15 14.3 7600 60 38 2 20 14 
9. 58900 9800 64 33 1 15 11.5 8800 68 30 2 18 12 
10. 58928 8100 63 33 4 25 13.5 7500 62 35 3 18 12.8 
11. 78755 7500 62 32 6 18 14.3 8200 58 40 2 18 14 
12. 77895 8100 60 35 5 12 10.5 8600 68 32 - 16 11 
13. 104995 8200 63 32 5 15 14 8200 66 28 6 22 13.6 
14. 103629 8300 63 35 2 15 11.5 8600 70 30 - 22 11 
15. 103830 10410 79 14 7 15 12.3 10100 64 30 6 30 13 
16. 105355 8000 66 31 3 17 13 7900 64 32 4 21 13.4 
17. 105373 8500 67 25 8 10 11.0 8000 62 38 - 12 11.2 
18. 17054 7300 60 37 3 10 11.3 7000 64 32 4 15 11 
19. 33003 7200 61 36 3 15 12.3 7800 62 33 5 18 14 
20. 38353 8200 64 31 5 11 13.4 8200 62 36 2 24 12 
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BIOCHEMICAL ANALYSIS 
 
 
S. 
NO 
 
OP. 
NO 
Blood 
Sugar 
Blood 
Urea 
Total 
Cholesterol 
Serum 
creatinine 
Bilirubin 
BFT 
AF
T 
BF
T 
AF
T 
BFT AFT 
BF
T 
AFT BFT 
AF
T 
1. 44662 93 89 22 20 169 175 0.7 0.4 0.5 0.2 
2. 44701 105 102 20 26 209 180 0.9 1.0 0.2 0.4 
3. 45298 88 120 26 30 125 143 0.7 0.5 0.5 0.3 
4. 47187 96 94 22 18 150 123 0.4 0.2 0.2 0.3 
5. 50375 80 96 25 22 216 200 0.6 0.6 0.5 0.2 
6 55421 84 102 23 22 146 160 0.6 0.4 0.5 0.2 
7. 55935 114 101 16 15 126 138 0.4 0.2 0.2 0.3 
8. 56318 67 95 22 18 142 165 0.6 0.5 0.4 0.2 
9. 58900 95 102 20 18 148 132 0.4 0.6 0.2 0.4 
10. 58928 116 95 22 20 160 129 0.4 0.5 0.2 0.3 
11. 78755 102 96 21 18 130 131 0.5 0.4 0.4 0.2 
12. 77895 89 104 16 15 128 136 0.5 0.2 0.4 0.3 
13. 104995 113 95 16 24 110 142 0.7 0.3 0.5 0.2 
14. 103629 116 120 20 18 128 140 1.0 0.9 0.2 0.3 
15. 103830 122 102 18 20 139 180 0.7 0.4 0.4 0.5 
16. 105355 130 142 16 20 206 178 0.7 0.6 0.2 0.2 
17. 105373 97 80 25 23 137 104 0.8 0.5 0.4 0.3 
18. 17054 117 128 21 18 166 126 0.8 0.4 0.5 0.3 
19. 33003 65 96 26 20 144 126 0.9 0.8 0.5 0.3 
20. 38353 96 104 18 22 162 146 0.4 0.2 0.2 0.1 
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URINE ANALYSIS 
S.NO OP. NO 
Before Treatment After Treatment 
Alb Sugar Pus 
cells 
Epi. 
cells RBC’S casts/crystals Alb Sugar Pus 
Epi. 
cells RBC’S casts/crystals 
1. 44662 Nil Nil NAD NAD NAD NAD Nil Nil 0-1 NAD NAD NAD 
2. 44701 Nil Nil 2-4 1-2 NAD NAD Nil Nil NAD NAD NAD NAD 
3. 45298 Nil Nil 5-7 1-2 NAD Full of calcium oxalate 
crystals Nil Nil 1-2 0-1 NAD NAD 
4. 47187 Trace Nil NAD NAD NAD Full of oxalate crystals Nil Nil NAD NAD NAD NAD 
5. 50375 Nil Nil 2-5 1-2 NAD NAD Nil Nil 0-1 NAD NAD NAD 
6. 55421 Nil Nil 5-7 NAD NAD NAD Nil Nil 0-2 1-2 NAD NAD 
7. 55935 Nil Nil 0-2 NAD NAD NAD Nil Nil NAD NAD NAD NAD 
8. 56318 Nil Nil 1-5 3-4 20-30 NAD Nil Nil NAD 0-1 NAD NAD 
9. 58900 Nil Nil 5-10 2-3 2-3 NAD Nil Nil NAD 0-1 NAD NAD 
10. 58928 Nil Nil 2-3 3-5 NAD NAD Nil Nil NAD 0-2 NAD NAD 
11. 78755 Nil Nil NAD few few NAD Nil Nil NAD 0-2 0-1 NAD 
12. 77895 Nil Nil 10-15 NAD 5-10 NAD Nil Nil 0-1 NAD NAD NAD 
13. 104995 Nil Nil NAD 1-2 NAD NAD Nil Nil NAD NAD NAD NAD 
14. 103629 Nil Nil 1-2 NAD NAD NAD Nil Nil NAD NAD NAD NAD 
15. 103830 Nil Nil few 3-5 NAD NAD Nil Nil 0-1 NAD NAD NAD 
16. 105355 Nil Nil few 1-2 NAD NAD Nil Nil 0-1 NAD NAD NAD 
17. 105373 Nil Nil 1-2 1-2 NAD NAD Nil Nil NAD NAD NAD NAD 
18. 17054 Nil Nil 1-2 2-3 NAD NAD Nil Nil NAD NAD NAD NAD 
19. 33003 Nil Nil 1-2 NAD 2-8 NAD Nil Nil NAD NAD NAD NAD 
20. 38353 Nil Nil 1-2 NAD 1-3 NAD Nil Nil NAD NAD NAD NAD 
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CASE SHEET OF 20 IN PATIENTS TREATED FOR KALLADAIPPU NOI 
S.NO IP.NO NAME 
A 
G 
E 
SEX Starting of treatment End of treatment No. 
of days treated Result 
1. 1600 RajaGopala Moorthy 62 M 21/06/2018 21/07/2018 30 Fair 
2. 1765 Avudaiammal 58 F 11/07/2018 10/08/2018 30 Fair 
3. 2360 Selvi 50 F 17/09/2018 15/10/2018 29 Good 
4. 2393 Mallika 48 F 21/09/2018 20/10/2018 30 Good 
5. 2772 Shanthi 53 F 14/11/2018 11/12/2018 28 Fair 
6. 5711 Meera 54 F 14/01/2019 13/02/2019 30 Fair 
7. 181 Sundari 43 F 28/01/2019 27/02/2019 30 Good 
8. 289 Sankarammal 45 F 08/02/2019 07/03/2019 30 Fair 
9. 311 Mani 30 M 11/02/2019 13/03/2019 30 Fair 
10. 388 Maharasi 48 F 16/02/2019 16/03/2019 30 Good 
11. 332 Daisy Rani 52 F 20/02/2019 22/03/2019 30 Good 
12. 448 Arumugam 50 F 21/02/2019 23/03/2019 30 Good 
13. 591 Pappa 50 F 07/03/2019 06/04/2019 30 Fair 
14. 776 Vijayalakshmi 50 F 26/03/2019 25/04/2019 30 Good 
15. 836 Subbulakshmi 51 F 01/04/2019 30/04/2019 30 Fair 
16. 855 Thamaraivadivu 54 F 02/04/2019 01/05/2019 30 Good 
17. 842 Boopathy 60 M 01/04/2019 30/04/2019 30 Fair 
18. 918 Tamilselvi 57 F 10/04/2019 10/05/2019 30 Good 
19. 1030 Saroja 55 F 25/04/2019 25/05/2019 30 Poor 
20. 1187 Shanmugathai 56 F 09/05/2019 25/05/2019 15 Fair 
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BIOCHEMICAL ANALYSIS 
 
S.NO 
 
 
IP.NO 
Before Treatment After Treatment 
WBC TC 
WBC-
DC% ESR  Hb% 
WBC Total cells/ 
cub.mm 
WBC-DC% ESR 
 
Hb% P L E ½ hr 1 hr P L E ½ hr 1 hr 
1. 1600 6600 52 42 6 - 20 13.8 6200 56 40 4 - 17 13.8 
2. 1765 7000 63 34 3 - 70 9.4 7600 65 33 2 - 20 10.1 
3. 2360 8900 64 33 3 - 12 13.8 8600 61 38 1 - 14 13.6 
4. 2393 8300 69 27 4 - 25 8.4 7900 55 43 2 - 18 9 
5. 2772 7200 68 31 1 - 20 10.5 7400 66 32 2 - 24 10.8 
6. 5711 6100 63 34 3 - 11 10.8 5800 59 36 5 - 12 11.2 
7. 181 8200 69 30 1 - 18 11.4 8400 64 30 6 - 19 12.4 
8. 289 6500 63 30 7 - 30 10.4 7600 58 38 4 - 16 11 
9. 311 7800 71 23 6 - 05 14.2 7900 65 32 3 - 06 14 
10. 388 8300 70 23 7 - 110 8.6 8600 62 35 3 - 52 9.5 
11. 332 7200 62 34 4 - 51 9.9 7800 65 30 5 - 26 11 
12. 448 6400 62 30 8 - 25 9.6 7000 68 31 1 - 18 10.4 
13. 591 9600 56 34 10 - 51 12.3 9700 59 37 4 - 20 14.2 
14. 776 8100 61 35 4 - 14 11.2 8400 62 37 1 - 12 12.1 
15. 836 6900 62 34 4 - 18 10.8 7000 58 34 8 - 16 11.5 
16. 855 7300 63 32 5 - 31 10.8 7800 61 35 4 - 18 11 
17. 842 6100 65 32 3 - 14 12.4 6700 63 32 5 - 11 13 
18. 918 5200 72 25 3 - 34 11 7000 58 40 2 - 28 11.5 
19. 1030 5800 58 40 2 - 30 12.4 5900 65 33 2 - 18 11.4 
20. 1187 6000 64 32 4 - 12 10 7100 60 32 8 - 17 10.8 
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BIOCHEMICAL ANALYSIS 
 
S.NO IP.NO Blood sugar 
Blood urea 
(mgs %) 
Total cholestrol 
(mgs %) Serum creatinine Bilirubin 
BFT AFT BFT AFT BFT AFT BFT AFT BFT AFT 
1. 1600 109 96 30 30 180 162 1.1 1.5 0.5 0.5 
2. 1765 176 126 19 32 189 158 0.6 0.9 0.5 0.5 
3. 2360 101 104 28 22 189 184 0.9 0.4 0.4 0.4 
4. 2393 97 94 20 21 166 165 0.9 0.9 0.5 0.5 
5. 2772 95 94 24 16 110 120 0.8 0.8 0.8 0.6 
6. 5711 93 193 27 25 193 164 0.9 0.9 0.7 0.7 
7. 181 103 104 33 27 182 160 0.4 0.9 0.5 0.4 
8. 289 122 128 23 21 126 162 0.5 0.6 0.6 0.6 
9. 311 84 96 21 19 168 158 0.7 0.9 0.5 0.5 
10 388 80 86 22 16 203 203 0.9 1.4 0.7 0.7 
11. 332 108 193 21 22 193 198 1.0 0.8 0.6 0.6 
12. 448 116 108 26 26 149 194 0.8 1.4 0.5 0.5 
13. 591 93 100 27 18 122 116 0.7 0.5 0.4 0.4 
14. 776 98 104 22 15 185 172 1.0 0.8 0.2 0.5 
15. 836 106 104 16 20 164 156 0.6 0.7 0.4 0.4 
16. 855 96 96 28 20 190 186 0.7 0.7 0.5 0.4 
17. 842 100 90 16 20 171 117 0.5 0.8 0.6 0.2 
18. 918 125 104 14 18 164 144 0.6 0.7 0.4 0.5 
19. 1030 111 120 18 20 182 128 0.9 0.9 0.3 0.5 
20. 1187 98 82 12 21 200 161 0.8 0.6 0.7 0.7 
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URINE ANALYSIS 
 
S.NO 
 
IP. 
NO 
Before Treatment After Treatment 
Alb Sugar Pus cells Epi. cells RBC’S Casts/ crystals Alb Sugar Pus cells Epi. cells RBC’S Casts/ crystals 
1. 1600 Nil Nil 1-2 1-2 NAD NAD Nil Nil NAD NAD NAD NAD 
2. 1765 + Nil 15-20 2-4 NAD NAD Nil Nil NAD NAD NAD NAD 
3. 2360 + Nil 1-4 few NAD NAD Nil Nil 0-1 NAD NAD NAD 
4. 2393 Nil Nil 1-2 0-1 NAD NAD Nil Nil NAD NAD NAD NAD 
5. 2772 Nil Nil 2-3 2-3 1-2 Few crystals Nil Nil NAD NAD NAD NAD 
6. 5711 Nil Nil 2-5 NAD 1-2 NAD Nil Nil 0-1 NAD NAD NAD 
7. 181 Nil Nil 1-2 NAD NAD NAD Nil Nil 0-2 NAD NAD NAD 
8. 289 Nil Nil 1-2 NAD NAD NAD Nil Nil NAD NAD NAD NAD 
9. 311 Nil Nil 1-2 NAD NAD NAD Nil Nil NAD NAD NAD NAD 
10. 388 Nil Nil 2-3 3-10 NAD NAD Nil Nil NAD NAD NAD NAD 
11. 332 Nil Nil NAD NAD NAD NAD Nil Nil NAD NAD NAD NAD 
12. 448 Nil Nil NAD NAD NAD NAD Nil Nil 0-1 NAD NAD NAD 
13. 591 Nil Nil 4-6 NAD NAD NAD Nil Nil NAD NAD NAD NAD 
14. 776 Nil Nil NAD 0-2 NAD NAD Nil Nil NAD NAD 0-1 NAD 
15. 836 Nil Nil 1-2 NAD 3-5 NAD Nil Nil NAD 0-1 NAD NAD 
16. 855 Nil Nil 1-2 1-2 5-6 NAD Nil Nil NAD NAD NAD NAD 
17. 842 Nil Nil 1-5 NAD NAD NAD Nil Nil 0-1 NAD NAD NAD 
18. 918 Nil Nil NAD NAD NAD NAD Nil Nil NAD NAD NAD NAD 
19. 1030 Nil Nil 2-5 NAD NAD few crystals Nil Nil NAD 0-1 NAD NAD 
20. 1187 Nil Nil NAD 0-2 1-2 NAD Nil Nil NAD NAD NAD NAD 
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CHAPTER-VI 
                                                        DISCUSSION 
 
My clinical study is “To evaluate the therapeutic efficacy of Open Labelled 
Phase II Non- Randomized  trial drug of  NERUNJI VER KUDINEER (Internal) in 
the treatment of KALLADAIPPU (Urolithiasis). Out of 20 out patients and 20 in 
patients were selected based on clinical features and modern investigations 
parameters and siddha diagnostic methods (Envagai Thervugal) were carried out after 
the disease.It is confirmed by ultrasonogram. The trial drug NERUNJI VER 
KUDINEER was prepared and given to the patients. The blood, urine samples and 
other general details were collected from the patients before and after treatment. The 
urolithiasis symptoms score of each patient before and after treatment were compared 
to assess the therapeutic value of the trail drug NERUNJI VER K UDINEER. 
AGE 
In this study, among the 20 out-patients, Kalladaippu  noi was  most common 
in Pitha Kaalam 34-66 years (70%). and among the 20  in-patients, it was 
predominant (95%) in Pitha Kaalam 34-66 years. 
SEX 
From the study, among the 20 outpatients (80%) were Male and (20%) were 
Female. Whereas among inpatients majority of them were Males (15%) and (85%) 
were Female cases. 
OCCUPATION 
From the data collected during the  enrollment of patients it was learnt that 
40% of the outpatients were Standing  workers, and 60% of the inpatients were 
Housewives.  
DIETARY HABITS 
Out of the 40 cases who were recruited for the study majority of them (90% of 
outpatients and 80% of inpatients) were taking  both Vegetarian and Non-Vegetarian 
items. 
MARITAL STATUS: 
 From the data collection, among the 40 patients majority of them (80% of        
out patients and 95% of in patients) were Married. 
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PERSONAL HABITS 
From the history taken from the patients it was noted that 60% of outpatients 
and 90% inpatients does not have any Bad Habits. 40% of outpatients and 10% 
inpatients have Alcoholism, Smoking, Alchohol with Smoking. 
PARUVAKAALAM 
In General, Kalladaippu Noi occurs in all the seasons. But in the present 
study, it was found to be the commonest during Ilavenil Kalam (40% outpatients 45% 
of inpatients) were affected. 
THINAI  
Among the patients who were selected for the trial 75% of the outpatients and 
80% of           the inpatients were from Marutha Nilam. 25% of outpatients were from 
Neithal Nilam, and 20% of inpatients were from Neithal Nilam. 
THEGI (CONSTITUTION OF BODY) 
In this study,Pitha Thegi patients were found to be the most affected by 
Kalladippu noi (70% of outpatients and 60% of inpatients), The second major were 
Vatha Thegi (20% of outpatients and 25% inpatients). Only a few of them (10% of 
outpatients and 15% of inpatients) were Kabam Thegi.  
MANO THATHUVAM (GUNAM) 
In this study, Rajo Gunam patients was affected by Kalladaippu noi (75% of 
out patients and 70% of in patients). The second major were Sathuva Gunam (20% of 
out patients and 15% of in patients). Only few of them (15% of out patients and 5% 
of in patients) were Thamo Gunam. 
UYIR THATHUKAL 
A. DERANGEMENT OF VATHAM 
In the contemporary study, it was noted that all the patients under treatment 
had disturbances in Abaanan , viyanan  and Samanan (100%)  which was the primary 
cause for oliguria, dysuria and formation of calculi. Pranan was affected in 15% of 
outpatients and 10% of  inpatients has cold and cough experienced by the patients.  
B. DERANGEMENT OF PITHAM 
It was noted that Sadhaga Pitham was affected in 80% of outpatients and 60% 
of inpatients resulting in power to complete the task and difficulty in their regular 
work in day to day life. Ranjaga Pitham was found to be disturbed in 5% of 
outpatients and 15% of inpatients. Analagapitham also disturbed in some patients. 
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C. DERANGEMENT OF KAPAM 
Santhigam was found to be affected in 30% of outpatients and 15% of 
inpatients, causing joint pain in elderly patients. Avalambagam was found to be in 5% 
of out patients. Kilethagam also affected in 35% of out patients and 25% of in 
patients. 
UDAL THATHUKKAL 
Among the patients selected for the study Saaram (100% of out patients and 
80% of in patients) was affected  causing sluggishness.  Enbu Thathu was found to be 
affected in (50% of out patients and 40% of inpatients) due to joint pain. Senneer was 
found to be affected in 20% of outpatients and 15% of inpatients. 
KOSANGAL 
Among the 40 patients, Annamayakosam (85%) was affected in all patients 
due to Udal Thathukal. Pranamayakosam was affected in ( 20% of out patients and 
15% of in patients) due to Pranan i.e cold and cough. 
14 VEGANGAL 
Among the 40 cases, controlling of  Siruneer (100%) was affected in all 
patients leads to Oliguria, Dysuria and Haematuria. Controlling of Nithirai was 
affected in few cases (30% of out patients and 35% of in patients) leads to Oliguria. 
ENVAGAI THAERVUGAL 
In this study, Moothiram (100%) was affected in all the patients.   Pitha Vatha 
Naadi was felt in most of the patients (60% of outpatients and 55% of inpatients).The 
second major type of  Naadi was  Vatha Pitha Naadi (35% of outpatients and 25% of 
inpatients).It was noticed that only 5% of the outpatients 20% of the inpatients had 
Vatha Kabha Naadi. Sparism was affected in 25% of out patients and 35% of in 
patients. 
NEERKURI 
It was noted that the urine colour was Yellowish ( 60% of outpatients and 
70% inpatients) and Yellowish Red in (20% of  out patients and 5% of in patients), it 
was normal in 10% of outpatients and 25% of inpatients. Nurai  normal in all the 
patients. Edai was affected in all the 40 patients (100%) due to Haematuria, Dysuria, 
and mixed with Calculus. Maanam was affected in all the patients (100%) due to 
Fleshy, Charred ,Ketotic Odour. Enjal was affected in ( 80% of out patients and 85% 
of in patients) due to Oliguria, Haematuria. 
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NEIKURI 
             When Neikuri was tested in the urine samples of the patients it was observed 
that  majority of them (65% of outpatients and 75% of inpatients) revealed that Pitha 
Neer. (20% of outpatients and 15% of inpatients) were Vatha Neer. (15% of out 
patients and 10% of in patients) were Kapha Neer. 
DURATION OF ILLNESS 
Majority of the patients experienced symptoms of Kalladaippu noi only in the 
past less than 8 weeks  (85% of outpatients and 90% of inpatients) and 2-6 months   
(10% of outpatients and 10% of inpatients). (5% of outpatients ) suffered from the 
disease from 6 month – 1 year. 
NUMBER OF STONES 
Before treatment majority of them have Single Stone (50% of out patients and 
55% of in patients), and Multiple Stones (50% of out patients and 45% of in patients). 
But after treatment (15% of out patients and 20% of in patients) have Single stone 
(Reducing in size of the stone) and Multiple Stones (20% of out patients and in 
patients) were affected. 
POSITION OF STONES 
The USG reports of the patients have stones which were mostly (45% of 
outpatients and 50% of inpatients) present in Left Kidney. In Right Kidney calculi 
were comparatively lesser (35% in outpatients and 40% in inpatients) and (10% of 
outpatients and 10% of inpatients) had stones in Both Kidneys. In Left Ureter (5% of 
out patients and 5% of in right ureter. 
SIZE OF STONES 
The USG reports of the cases before treatment showed that majority of the 
cases (60% of the outpatients and 20% of the inpatients) presented with stone of size 
5mm and above. And 4-5mm (10% of out patients and 40% of in patients). And 1-
3mm (30% of out patients and 25% in patients) were affected. After treatment  (35% 
of out patients and 35% of in patients) have normal study report and have no 
symptoms. Thus the Statistics Analysis also considered as SIGNIFICANT P<0.0001. 
UROLITHIASIS SYMPTOMS SCORE  
 From the above study, Before treatment the patients  (25% of out patients 
and 35% of in patients) were Severely affected. And (60% of out patients and 65% 
in patients) were Moderately affected. After treatment most of  the patients (15% of 
out patients and 20% of in patients) have No Symptoms that is Normal Study and 
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also Relief in Symptoms. And (15% of out patients ) have Mild scores. And also 
(15% of out patients and 20% of in patients) have Moderately affected ( reducing in 
stone size and relief in symptoms). Thus the Analysis also considered as 
SIGNIFICANT P<0.0001. 
GRADING OUTCOME OF THE STUDY  
The trail medicine selected for the clinical study was NERUNJI VER 
KUDINEER - 100ml BD Morning & Evening . The present study proved the 
therapeutic values of the trial medicine which is evident from the Absence of Calculi 
and Symptoms associated with Kalladaippu Noi in majority of the patients. Good 
response was noticed in (75% of outpatients and 50% of inpatients) and Moderate 
response in (25% of outpatients and 45% of inpatients). The good and moderate 
response of trial drug in treating Kalladaippu noi is attributed to the lithotriptic, 
diuretic and analgesic effects of the trial medicine. 
STATISTICAL ANALYSIS :    
Statistical Analysis of the Size of Stone : 
The mean value of size of the stone (mm) before and after treatment was 
respectively 6.5375 & 2.7750 and the standard deviation was 5.45540 & 
3.60190.Pearson correlation ( ) before and after treatment among in patients size of 
stone is 0.856. P- value followed to be less than 0.0001 is considered to be extremely 
statistically significant. There is strong evidence (t= 4.873, P< 0.0001) that the 
clinical trial drug importance the Kalladaippu patients. In this data set we could get a 
mean paired difference, df =39, with the confidence interval of 95% the null 
hypothesis is rejected, since P<0.0001.  
Statistical analysis of the Urolithiasis Symptom Score : 
The mean value of Urolithiasis Symptom Score before and after treatment was 
respectively 12.4000 & 1.7250 and the standard deviation was 4.17440 & 3.55894. 
Pearson correlation ( ) before and after treatment of  Urolithiasis Symptom Score 
among in patients is -0.196. P- value followed to be less than 0.0001 is considered to 
be extremely statistically significant. There is strong evidence (t=3.065, P< 0.0001) 
that the clinical trial drug importance the Kalladaippu patients. In this data set we 
could get a mean paired difference, df =39, with the confidence interval of 95% the 
null hypothesis is rejected, since P<0.0001.  
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CHAPTER-VII 
SUMMARY 
 
 The aim of the study is to Evaluate the therapeutic efficacy of the drug   
NERUNJI VER KUDINEER  in KALLADAIPPU. 
 Before intiating the clinical trial, got approval from INSTITUTIONAL 
ETHICAL COMMITTEE (IEC) in Government Siddha Medical College. 
Palayamkottai. Tirunelveli. And got approval from INSTITUTIONAL 
ANIMAL ETHICAL COMMITTEE (IAEC) at K.M.COLLEGE OF 
PHARMACY, MADURAI. 
 The drugs were authenticated, and also done Biochemical Analysis in Govt. 
Siddha Medical College, Palayamkottai. Tirunelveli. 
 The drug undergo Pharmacological Study has done at K.M. College of 
Pharmacy, Madurai. Microbial study also done at Inbiotics at Nagercoil. 
 For clinical study, among 40 cases were selected and recruited for the clinical 
trial, clinical diagnosis made by both Siddha and modern methodology. 
 Before initiating the trial informed consent was obtained from the patients. 
 All the patients were treated for a period of 30 days. The trial medicine 
selected for internal treatment was  NERUNJI VER KUDINEER  at the dose 
of 100ml twice a day referred under Siddha literature  
ATHMARATCHAMIRTHAM ENNUM VAIDHYA SARASANGIRAGAM, 
Page.no.349. 
 Required laboratory investigations were carried out before and after treatment 
and the concerned data was recorded in the proforma. 
 Clinical assessment was done during each visit in OPD Patients (2 days once) 
and the data was noted in the prescribed proforma. 
 During the study period there was no event of any adverse reactions owing to 
the drug and disease. 
 The patients were showed good prognosis within a short period, Oliguria and 
Burning Micturation reduced within 7 days of treatment.  
 It is observed that all other signs and symptoms relived at the end of course of 
treatment with the trial medicine and strict diet restriction.  
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 From the clinical examination and enquiring the patients, it was noted that 
stones were broken into fragments and expelled out in the form of sand grains 
and travels with urine. It is evident from the ultrasonographic investigations 
that the trial medicine helped in disintegrate of the calculus in some patients. 
 Statistical Analysis of Urolithiasis Symptoms Score also shows significant 
P<0.0001. 
 Among 40 cases, Good response was noticed in 75% of OPD and 50% of IPD. 
And Moderate response in 25% of OPD and 45% of IPD. Poor response in 5% 
of  IPD. 
 In this study, it has been proved that the trial medicine, NERUNJI VER  
KUDINEER (Internal) is highly effective and economically viable in curing 
KALLADAIPPU NOI. 
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CHAPTER VIII 
CONCLUSION 
            The following conclusions have been drawn from the A Prospective Open 
Labelled Phase II Non- Randomized Clinical Trial on “The evaluation of efficacy of 
the drug, (internal) in NERUNJI VER KUDINEER  treating KALLADAIPPU NOI 
was carried out at the PG Department of Pothu Maruthuvam, Government Siddha 
Medical College and Hospital, Palayamkottai as my dissertation work. 
1. The Ingredients incorporated in the trial medicine helped to cure 
Kalladaippu Noi by compensating the increased Pitham which is 
attributed to the Diuretic, Lithotriptic action, Analgesic effect, as 
mentioned in the various Siddha Literatures.  
2. The Biochemical Analysis of trial medicine revealed that the presence 
of various minerals like Calcium, Sulphate, Chloride, Ferrous Iron 
and Unsaturated Compounds . 
3. The Pharmacological Study on trial medicine was confirmed the 
Lithotriptic, diuretic and analgesic  effect of the medicine. 
4. The Microbial Analysis showed a very sensitive to my trial drug of 
NERUNJI VER KUDINEER of Staphylococcus aureus, 
Streptococcus mutans ,Bacillus subtilis and E.coli. 
5. The Ultra Sonogram Reports of some  patients Before treatment and 
After treatment were compared to evaluate the prognosis in patients. 
6. Clinically, the trial medicine is free from side effects as no patient 
experienced side effects during the course of treatment. 
7. The result showed Good Response in 75% of OPD and 50% of IPD  
and Moderate Response in 25% of OPD  and 50% of IPD. 
The Medicine was found to have Lithotriptic, Diuretic, Analgesic effect, and 
have properties to compensate the increased Pitham, which is one of the important 
causes for Kalladaippu Noi.  From this study, it has been proved that the trial 
medicine of NERUNJI VER KUDINEER is highly effective in curing 
KALLADAIPPU NOI. 
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